https://curecurrent.com/trials/detecting-recurrent-prostate-cancer-with-c-11-choline-positron-emission-tomography-an-expanded-access-study-60001https://curecurrent.com/trials/docetaxel-doxorubicin-and-prednisone-in-treating-patients-with-advanced-prostate-cancer-that-has-not-responded-to-hormon-60002https://curecurrent.com/trials/effects-on-dihydrotestosterone-regulated-gene-expression-in-benign-prostatic-hyperplasia-or-prostate-cancer-60003https://curecurrent.com/trials/biomarkers-in-patients-undergoing-transrectal-ultrasound-prostate-biopsy-60004https://curecurrent.com/trials/assessment-of-dutasteride-avodart-in-extending-the-time-to-progression-of-low-risk-localized-prostate-cancer-in-men-60005https://curecurrent.com/trials/early-phase-safety-of-proton-therapy-equipment-60006https://curecurrent.com/trials/18f-fch-fluorocholine-pet-mr-in-staging-of-high-risk-prostate-cancer-60007https://curecurrent.com/trials/evaluation-of-lithium-and-it-s-effect-on-clinically-localized-prostate-cancer-60008https://curecurrent.com/trials/a-clinical-research-of-car-t-cells-targeting-epcam-positive-cancer-60009https://curecurrent.com/trials/using-magnetic-resonance-imaging-mri-to-guide-differential-dose-prostate-brachytherapy-60010https://curecurrent.com/trials/a-study-of-alpharadin-with-docetaxel-in-patients-with-bone-metastasis-from-castration-resistant-prostate-cancer-crpc-60011https://curecurrent.com/trials/153sm-edtmp-with-or-without-a-psa-tricom-vaccine-to-treat-men-with-androgen-insensitive-prostate-cancer-60012https://curecurrent.com/trials/immune-monitoring-on-sipuleucel-t-60013https://curecurrent.com/trials/the-use-of-thermal-suits-as-preventing-hypothermia-during-surgery-60014https://curecurrent.com/trials/the-role-of-c-11-choline-pet-in-patients-with-prostate-cancer-60015https://curecurrent.com/trials/radiation-therapy-and-hormone-therapy-in-treating-patients-with-prostate-cancer-60016https://curecurrent.com/trials/addressing-prostate-cancer-information-disparities-with-ehealth-technology-60017https://curecurrent.com/trials/eligard-observational-registry-for-patients-with-prostate-cancer-60018https://curecurrent.com/trials/hormone-sensitive-prostate-cancer-patients-switched-to-degarelix-therapy-after-failing-on-gnrh-agonists-60019https://curecurrent.com/trials/trial-assessing-zactima-against-placebo-in-prostate-cancer-subjects-undergoing-intermittent-androgen-deprivation-hormona-60020https://curecurrent.com/trials/quality-of-life-after-permanent-interstitial-iodine-seed-prostate-brachytherapy-60021https://curecurrent.com/trials/mri-temperature-mapping-of-the-prostate-and-urogenital-pelvis-cooled-by-an-endorectal-balloon-60022https://curecurrent.com/trials/a-study-of-degarelix-in-patients-with-prostate-cancer-60023https://curecurrent.com/trials/mitoxantrone-cetuximab-2nd-line-androgen-independent-prostate-cancer-aipc-60024https://curecurrent.com/trials/neoadjuvant-docetaxel-on-newly-diagnosed-intermediate-and-high-grade-cancer-of-the-prostate-60025https://curecurrent.com/trials/calcium-with-or-without-estrogen-and-or-risedronate-in-preventing-osteoporosis-in-patients-with-prostate-cancer-60026https://curecurrent.com/trials/efficacy-and-safety-of-zactima-in-patients-with-castration-refractory-metastatic-prostate-cancer-60027https://curecurrent.com/trials/bipolar-androgen-based-therapy-for-prostate-cancer-bat-60028https://curecurrent.com/trials/cabozantinib-xl184-in-men-with-castrate-resistant-prostate-cancer-60029https://curecurrent.com/trials/intensity-modulated-radiation-therapy-from-70gy-to-80gy-in-localized-prostate-cancer-60030https://curecurrent.com/trials/utilizing-mri-to-study-the-effect-of-sulforaphane-on-prostate-cancer-60031https://curecurrent.com/trials/a-study-of-the-clinical-activity-and-safety-of-jnj-64041809-a-live-attenuated-listeria-monocytogenes-immunotherapy-in-co-60032https://curecurrent.com/trials/randomized-amniofix-study-during-radical-prostatectomy-60033https://curecurrent.com/trials/combined-antiinflammatory-and-angiostatic-therapy-in-patients-with-hormone-refractory-prostate-cancer-60034https://curecurrent.com/trials/ig-vmat-for-localized-prostate-cancer-60035https://curecurrent.com/trials/evaluation-of-bone-markers-as-diagnostic-tools-for-early-detection-of-bone-metastases-in-patients-with-high-risk-prostat-60036https://curecurrent.com/trials/study-of-effectiveness-of-lovastatin-to-prevent-radiation-induced-rectal-injury-60037https://curecurrent.com/trials/microrna-profiles-identification-in-adeno-carcinoma-prostate-cancer-60038https://curecurrent.com/trials/effects-of-sulforaphane-on-normal-prostate-tissue-60039https://curecurrent.com/trials/prevention-of-lymphoceles-after-robotic-plnd-60040https://curecurrent.com/trials/hormone-ablation-therapy-doxorubicin-and-zoledronate-with-or-without-strontium-89-in-treating-patients-with-androgen-dep-60041https://curecurrent.com/trials/weuskop5723-prostate-cancer-study-60042https://curecurrent.com/trials/symptom-management-in-african-american-men-with-localized-prostate-cancer-60043https://curecurrent.com/trials/cooking-class-intervention-project-for-men-with-prostate-cancer-and-their-partners-60044https://curecurrent.com/trials/to-evaluate-the-technique-and-effects-of-separating-the-prostate-and-rectum-with-hyaluronic-acid-during-radiotherapy-60045https://curecurrent.com/trials/identifying-prostate-brachytherapy-seeds-using-mri-60046https://curecurrent.com/trials/intervention-trial-evaluating-focal-therapy-using-high-intensity-focused-ultrasound-for-the-treatment-of-prostate-cancer-60047https://curecurrent.com/trials/serial-mpmri-multi-parametric-magnetic-resonance-imaging-scanning-in-prostate-cancer-after-androgen-deprivation-therapy-60048https://curecurrent.com/trials/lenalidomide-and-paclitaxel-in-prostate-cancer-60049https://curecurrent.com/trials/second-line-chemotherapy-in-castration-resistant-prostate-cancer-60050https://curecurrent.com/trials/androgen-deprivation-therapy-bevacizumab-for-psa-recurrence-of-prostate-cancer-after-definitive-local-therapy-60051https://curecurrent.com/trials/preoperative-staging-and-dose-escalated-radiotherapy-of-prostate-carcinoma-with-pet-and-mri-60052https://curecurrent.com/trials/development-and-validation-of-novel-mri-methods-for-the-detection-of-prostate-cancer-aggressiveness-60053https://curecurrent.com/trials/localising-occult-prostate-cancer-metastases-with-advanced-imaging-techniques-60054https://curecurrent.com/trials/evaluation-and-predictive-value-of-genetic-polymorphisms-in-the-management-of-hormonal-treatment-of-prostate-cancer-60055https://curecurrent.com/trials/motorised-probe-holder-assisting-prostate-biopsies-60056https://curecurrent.com/trials/merging-of-endoscopic-and-ultrasound-images-for-laparoscopic-surgery-60057https://curecurrent.com/trials/multiparametric-mri-for-prostate-cancer-localization-and-characterization-new-methods-60058https://curecurrent.com/trials/randomized-study-comparing-docetaxel-plus-dasatinib-to-docetaxel-plus-placebo-in-castration-resistant-prostate-cancer-60059https://curecurrent.com/trials/carbon-ion-radiotherapy-in-treating-patients-undergoing-systemic-therapy-for-oligo-metastatic-prostate-cancer-60060https://curecurrent.com/trials/safety-biodistribution-radiation-dosimetry-and-pharmacokinetics-study-of-bay88-8223-in-japanese-patients-60061https://curecurrent.com/trials/a-six-month-open-label-crossover-study-of-the-maintenance-of-serum-testosterone-and-psa-suppression-after-switching-betw-60062https://curecurrent.com/trials/comparing-0-5-mg-dutasteride-vs-placebo-daily-in-men-receiving-androgen-ablation-therapy-for-prostate-cancer-60063https://curecurrent.com/trials/comparison-of-docetaxel-prednisone-to-docetaxel-prednisone-in-combination-with-ogx-011-in-men-with-prostate-cancer-60064https://curecurrent.com/trials/active-surveillance-magnetic-resonance-imaging-study-60065https://curecurrent.com/trials/radium-223-following-intermittent-adt-60066https://curecurrent.com/trials/a-study-evaluating-the-pain-palliation-benefit-of-adding-custirsen-to-docetaxel-retreatment-or-cabazitaxel-as-second-lin-60067https://curecurrent.com/trials/comparison-of-cabazitaxel-prednisone-alone-or-in-combination-with-custirsen-for-2nd-line-chemotherapy-in-prostate-cancer-60068https://curecurrent.com/trials/safety-and-efficacy-of-intravenous-tranexamic-acid-in-endoscopic-transurethral-resections-in-urology-60069https://curecurrent.com/trials/whole-body-bone-scan-vs-18f-choline-pet-ct-in-prostate-cancer-60070https://curecurrent.com/trials/e3-hormone-refractory-prostrate-cancer-taxotere-combination-60071https://curecurrent.com/trials/s9346a-blood-samples-from-patients-with-metastatic-prostate-cancer-previously-treated-with-bicalutamide-and-goserelin-60072https://curecurrent.com/trials/dose-finding-study-of-afuresertib-administered-in-combination-with-either-enzalutamide-or-aibraterone-60073https://curecurrent.com/trials/hyaluronic-acid-for-hypofractionated-prostate-radiotherapy-60074https://curecurrent.com/trials/a-study-of-the-safety-and-pharmacokinetics-of-escalating-doses-of-dstp3086s-in-patients-with-metastatic-castration-resis-60075https://curecurrent.com/trials/study-of-immunotherapy-to-treat-advanced-prostate-cancer-60076https://curecurrent.com/trials/hypofractionated-intensity-modulated-radiation-therapy-plus-hormonal-therapy-in-patients-with-high-risk-prostate-cancer-60077https://curecurrent.com/trials/reduce-a-clinical-research-study-to-reduce-the-incidence-of-prostate-cancer-in-men-who-are-at-increased-risk-60078https://curecurrent.com/trials/trial-to-evaluate-radiotherapy-followed-by-endocrine-therapy-vs-endocrine-therapy-alone-for-psa-failure-after-radical-pr-60079https://curecurrent.com/trials/neoadjuvant-hormones-docetaxel-in-node-positive-prostate-cancer-60080https://curecurrent.com/trials/a-study-evaluating-vaccination-of-prostate-cancer-patients-with-self-dendritic-cells-expressing-muc1-60081https://curecurrent.com/trials/medical-and-economic-evaluation-for-intermediate-risk-prostate-cancer-60082https://curecurrent.com/trials/prospective-rct-on-post-prostatectomy-urine-leak-60083https://curecurrent.com/trials/neoadjuvant-chemotherapy-with-cabazitaxel-60084https://curecurrent.com/trials/energy-balance-for-prostate-cancer-survivorship-60085https://curecurrent.com/trials/radiation-therapy-with-or-without-bicalutamide-and-goserelin-in-treating-patients-with-prostate-cancer-60086https://curecurrent.com/trials/evaluation-of-a-transrectal-scintigraphic-detector-proxiscantm-for-detection-of-primary-prostate-cancer-60087https://curecurrent.com/trials/carbon-11-acetate-and-fluorine-f-18-sodium-fluoride-pet-as-a-biomarker-of-treatment-response-in-patients-with-hormone-re-60088https://curecurrent.com/trials/determinants-of-quality-of-life-in-aged-cancer-patients-60089https://curecurrent.com/trials/evaluation-of-the-accuracy-of-the-elastic-fusion-mri-ultrasound-obtained-in-vivo-by-the-koelis-system-60090https://curecurrent.com/trials/for-cause-prostate-biopsy-in-reduce-population-trial-60091https://curecurrent.com/trials/mr-targeted-vs-random-trus-guided-prostate-biopsy-60092https://curecurrent.com/trials/phase-3-study-of-immunotherapy-to-treat-advanced-prostate-cancer-60093https://curecurrent.com/trials/a-comparison-of-totally-intravenous-and-inhalation-anesthesia-for-intraocular-pressure-during-robot-assisted-laparoscopi-60094https://curecurrent.com/trials/cabazitaxel-in-mcrpc-patients-with-ar-v7-positive-ctcs-60095https://curecurrent.com/trials/institut-paoli-calmettes-prostate-cancer-database-60096https://curecurrent.com/trials/an-observational-study-looking-at-how-well-the-drug-eligard-works-and-how-well-it-is-tolerated-by-the-body-of-patients-w-60097https://curecurrent.com/trials/a-study-to-assess-the-effects-of-mk0822-in-prolonging-time-to-first-bone-metastasis-in-men-with-castration-resistant-pro-60098https://curecurrent.com/trials/information-improvement-for-surgical-patients-through-portable-video-media-60099https://curecurrent.com/trials/wb-dw-mri-vs-choline-pet-ct-for-selecting-treatments-in-recurrent-prostate-cancer-60100https://curecurrent.com/trials/cancer-diagnosis-by-multiparametric-ultrasound-of-the-prostate-60101https://curecurrent.com/trials/cholecalciferol-and-genistein-before-surgery-in-treating-patients-with-early-stage-prostate-cancer-60102https://curecurrent.com/trials/a-study-of-the-effectiveness-of-pomegranate-pills-in-men-with-prostate-cancer-before-prostatectomy-60103https://curecurrent.com/trials/point-in-time-of-radiotherapy-for-patients-with-biochemical-recurrent-prostate-carcinoma-60104https://curecurrent.com/trials/socioeconomic-aspects-before-and-after-radiation-therapy-in-patient-with-prostate-cancer-60105https://curecurrent.com/trials/pemetrexed-as-second-line-therapy-in-treating-patients-with-hormone-refractory-prostate-cancer-60106https://curecurrent.com/trials/cabazitaxel-and-abiraterone-acetate-in-patients-with-metastatic-castrate-resistant-prostate-cancer-60107https://curecurrent.com/trials/evaluate-safety-and-tolerability-of-intraprostatic-prx302-administration-low-to-intermediate-risk-prostate-cancer-60108https://curecurrent.com/trials/improved-prostate-cancer-diagnosis-combination-of-rapid-prebiopsy-magnetic-resonance-imaging-and-biomarkers-60109https://curecurrent.com/trials/study-to-determine-the-feasibility-evaluability-and-variability-in-markers-of-drug-action-in-castration-resistant-prosta-60110https://curecurrent.com/trials/male-stress-urinary-incontinence-and-sexual-health-60111https://curecurrent.com/trials/aflibercept-in-combination-with-docetaxel-in-metastatic-androgen-independent-prostate-cancer-60112https://curecurrent.com/trials/a-clinical-trial-to-study-dr-2031-for-the-treatment-of-hot-flashes-in-prostate-cancer-patients-60113https://curecurrent.com/trials/clinical-trial-comparing-3-d-rt-vs-imrt-in-post-prostatectomy-prostate-cancer-patients-60114https://curecurrent.com/trials/combination-hormone-therapy-followed-by-radiation-therapy-in-treating-patients-with-prostate-cancer-60115https://curecurrent.com/trials/icg-based-fluorescence-imaging-in-localization-of-prostate-cancer-and-metastatic-lymph-nodes-60116https://curecurrent.com/trials/soy-protein-supplement-in-preventing-prostate-cancer-in-patients-with-elevated-prostate-specific-antigen-levels-60117https://curecurrent.com/trials/magnetic-resonance-mr-spectroscopy-in-localized-prostate-cancer-60118https://curecurrent.com/trials/androgen-suppression-plus-radiation-therapy-in-treating-patients-with-prostate-cancer-60119https://curecurrent.com/trials/combination-chemotherapy-plus-filgrastim-in-treating-patients-with-stage-iv-prostate-cancer-that-has-not-responded-to-ho-60120https://curecurrent.com/trials/gene-mutations-in-patients-with-advanced-prostate-cancer-that-is-not-responsive-to-hormone-therapy-60121https://curecurrent.com/trials/flutamide-in-the-prevention-of-prostate-cancer-in-patients-with-neoplasia-of-the-prostate-60122https://curecurrent.com/trials/nitrocamptothecin-in-treating-patients-with-stage-iv-prostate-cancer-that-has-not-responded-to-hormone-therapy-60123https://curecurrent.com/trials/mitoxantrone-following-surgery-in-treating-patients-with-prostate-cancer-at-high-risk-for-recurrence-60124https://curecurrent.com/trials/octreotide-in-preventing-diarrhea-in-patients-who-are-undergoing-radiation-therapy-to-the-pelvis-60125https://curecurrent.com/trials/hormone-therapy-followed-by-internal-radiation-therapy-in-treating-patients-with-locally-recurrent-prostate-cancer-60126https://curecurrent.com/trials/lycopene-in-treating-patients-with-metastatic-prostate-cancer-60127https://curecurrent.com/trials/green-tea-extract-in-treating-patients-with-metastatic-prostate-cancer-that-has-not-responded-to-hormone-therapy-60128https://curecurrent.com/trials/muc1-vaccine-in-conjunction-with-poly-iclc-in-patients-with-recurrent-and-or-advanced-prostate-cancer-60129https://curecurrent.com/trials/immediate-versus-deferred-androgen-deprivation-therapy-goserelin-for-recurrent-prostate-cancer-after-radical-radiotherap-60130https://curecurrent.com/trials/a-prospective-randomized-trial-of-two-different-prostate-biopsy-schemes-60131https://curecurrent.com/trials/quantification-of-contrast-enhanced-ultrasound-ceus-in-the-detection-of-prostate-cancer-60132https://curecurrent.com/trials/chemotherapy-hormone-therapy-and-radiation-therapy-in-treating-patients-with-locally-advanced-prostate-cancer-60133https://curecurrent.com/trials/biological-investigations-in-active-surveillance-bias-igar-2008-i-19-in-prostate-cancer-using-high-field-mri-3-tesla-pet-60134https://curecurrent.com/trials/the-role-of-tomotherapy-in-hypofractionated-dose-escalated-conformal-radiation-treatment-for-high-risk-prostate-cancer-60135https://curecurrent.com/trials/chemotherapy-plus-radiation-therapy-in-treating-patients-with-unresectable-residual-or-recurrent-colorectal-cancer-60136https://curecurrent.com/trials/study-of-cabazitaxel-combined-with-prednisone-and-prophylaxis-of-neutropenia-complications-in-the-treatment-of-patients-60137https://curecurrent.com/trials/surgery-in-treating-patients-with-prostate-cancer-60138https://curecurrent.com/trials/surgery-versus-internal-radiation-in-treating-patients-with-stage-ii-prostate-cancer-60139https://curecurrent.com/trials/quality-of-life-in-patients-undergoing-surgery-or-brachytherapy-for-stage-ii-prostate-cancer-60140https://curecurrent.com/trials/hormone-therapy-in-treating-patients-with-prostate-cancer-60141https://curecurrent.com/trials/hsv-tk-valacyclovir-therapy-in-combination-with-brachytherapy-for-recurrent-prostate-cancer-60142https://curecurrent.com/trials/docetaxel-estramustine-and-exisulind-in-treating-patients-with-metastatic-prostate-cancer-that-has-not-responded-to-horm-60143https://curecurrent.com/trials/a-phase-iib-study-to-evaluate-efficacy-and-tolerability-of-odx-osteodex-in-metastatic-crpc-60144https://curecurrent.com/trials/docetaxel-taxotere-and-imatinib-mesylate-gleevec-in-hormone-refractory-prostate-cancer-60145https://curecurrent.com/trials/pet-ct-mri-in-the-radiotherapy-for-prostate-cancer-60146https://curecurrent.com/trials/registry-and-database-lap-prostatectomy-60147https://curecurrent.com/trials/gabapentin-in-treating-hot-flashes-in-patients-with-prostate-cancer-60148https://curecurrent.com/trials/antiandrogen-withdrawal-in-treating-patients-with-hormone-refractory-prostate-cancer-60149https://curecurrent.com/trials/prime-prostate-imaging-for-margin-evaluation-60150https://curecurrent.com/trials/methylprednisolone-with-or-without-doxorubicin-in-treating-patients-with-metastatic-prostate-cancer-60151https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-prostate-cancer-60152https://curecurrent.com/trials/digital-application-usage-for-adherence-of-patients-undergoing-robotic-assisted-radical-prostatectomy-following-oncologi-60153https://curecurrent.com/trials/facbc-pet-ct-for-recurrent-prostate-cancer-60154https://curecurrent.com/trials/trial-of-anti-psma-designer-t-cells-in-advanced-prostate-cancer-after-non-myeloablative-conditioning-60155https://curecurrent.com/trials/trial-of-anti-psma-designer-t-cells-in-advanced-prostate-cancer-after-non-myeloablative-conditioning-60156https://curecurrent.com/trials/ultrasound-imaging-in-finding-prostate-cancer-in-patients-undergoing-surgery-60157https://curecurrent.com/trials/an-open-label-randomised-trial-of-rnactive-cancer-vaccine-in-high-risk-and-intermediate-risk-patients-with-prostate-canc-60158https://curecurrent.com/trials/tak-700-in-castration-resistant-prostate-cancer-60159https://curecurrent.com/trials/embrace1-prostate-biorepository-60160https://curecurrent.com/trials/a-phase-i-ii-study-of-azacitidine-docetaxel-and-prednisone-for-metastatic-prostate-cancer-patients-60161https://curecurrent.com/trials/a-phase-1-study-to-evaluate-the-effects-of-fluconazole-and-atorvastatin-on-the-pharmacokinetics-of-tak-385-in-healthy-su-60162https://curecurrent.com/trials/intravenous-vegf-trap-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-or-non-hodgkin-s-lymphoma-60163https://curecurrent.com/trials/intravenous-vegf-trap-in-treating-patients-with-relapsed-or-refractory-advanced-solid-tumors-or-non-hodgkin-s-lymphoma-60164https://curecurrent.com/trials/deformable-registration-of-multi-parametric-mri-to-intra-operative-transrectal-ultrasound-for-prostate-brachytherapy-60165https://curecurrent.com/trials/evaluation-of-safety-of-cabazitaxel-jevtana-in-patients-with-metastatic-hormone-refractory-prostate-cancer-60166https://curecurrent.com/trials/study-to-investigate-the-effects-of-orteronel-on-the-qt-qtc-interval-in-patients-with-metastatic-castration-resistant-pr-60167https://curecurrent.com/trials/assessment-of-bone-loss-in-men-receiving-treatment-for-prostate-cancer-60168https://curecurrent.com/trials/risedronate-to-prevent-skeletal-related-events-in-patients-with-metastatic-prostate-cancer-commencing-hormonal-therapy-60169https://curecurrent.com/trials/effects-of-asa-on-prostate-tissue-60170https://curecurrent.com/trials/imaging-of-residual-tumor-during-prostatectomy-60171https://curecurrent.com/trials/everolimus-bicalutamide-and-leuprolide-acetate-in-treating-patients-undergoing-radiation-therapy-for-high-risk-locally-a-60172https://curecurrent.com/trials/reduced-planning-target-volume-ptv-margins-for-the-treatment-of-prostate-cancer-using-the-calypso-4d-localization-system-60173https://curecurrent.com/trials/role-of-dutasteride-in-patients-undergoing-3d-mapping-biopsy-in-early-stage-prostate-cancer-60174https://curecurrent.com/trials/the-effect-of-guardix-solution-for-the-prevention-of-postoperative-intestinal-adhesion-and-intestinal-obstruction-after-60175https://curecurrent.com/trials/external-immobilization-compared-to-limited-immobilization-using-a-novel-real-time-localization-system-of-the-prostate-60176https://curecurrent.com/trials/the-use-of-rad001-with-docetaxel-in-the-treatment-of-metastatic-androgen-independent-prostate-cancer-60177https://curecurrent.com/trials/neoadjuvant-bevacizumab-plus-docetaxel-in-high-risk-patients-with-prostate-cancer-undergoing-radical-prostatectomy-60178https://curecurrent.com/trials/epidemiologic-clinical-and-genetic-profile-of-prostate-cancer-in-arab-countries-60179https://curecurrent.com/trials/stereotactic-volumetric-radiotherapy-in-prostate-cancer-60180https://curecurrent.com/trials/study-of-lenalidomide-and-docetaxel-in-subjects-with-androgen-independent-prostate-cancer-60181https://curecurrent.com/trials/a-pilot-study-of-parenteral-testosterone-and-oral-etoposide-as-therapy-for-men-with-castration-resistant-prostate-cancer-60182https://curecurrent.com/trials/efficacy-study-evaluating-chemotherapy-in-prostate-cancer-60183https://curecurrent.com/trials/efficiency-study-of-aspirin-to-prevent-the-occurrence-of-prostate-cancer-60184https://curecurrent.com/trials/cilengitide-in-treating-patients-with-prostate-cancer-60185https://curecurrent.com/trials/f-choline-pet-in-early-response-assessment-for-castration-resistant-prostatic-cancer-60186https://curecurrent.com/trials/positioning-and-tracking-the-prostate-during-external-beam-radiation-60187https://curecurrent.com/trials/treatment-of-advanced-castration-resistant-prostate-carcinoma-with-limited-bone-metastases-rt-60188https://curecurrent.com/trials/volume-controlled-ventilation-vs-autoflow-volume-controlled-ventilation-60189https://curecurrent.com/trials/brassica-vegetables-or-indole-3-carbinol-in-treating-patients-with-psa-recurrence-after-surgery-for-prostate-cancer-60190https://curecurrent.com/trials/comparison-of-trelstar-versus-lupron-or-zoladex-in-advanced-prostate-cancer-60191https://curecurrent.com/trials/evaluation-of-psa-blood-levels-prior-to-and-after-digital-rectal-examination-60192https://curecurrent.com/trials/anatomical-and-functional-differences-between-continent-and-incontinent-men-post-radical-prostatectomy-60193https://curecurrent.com/trials/68ga-nota-bbn-rgd-pet-ct-in-prostate-cancer-patients-60194https://curecurrent.com/trials/changes-of-immunologic-function-in-patients-of-prostate-cancer-induced-after-cryoablation-60195https://curecurrent.com/trials/efficacy-safety-and-quality-of-life-after-tookad-soluble-vtp-for-localized-prostate-cancer-60196https://curecurrent.com/trials/understanding-and-discouraging-overuse-of-potentially-harmful-screening-tests-60197https://curecurrent.com/trials/zoledronic-associated-with-hight-hypofractionated-radiotherapy-dose-in-bone-metastases-vertebral-prostate-adenocarcinoma-60198https://curecurrent.com/trials/study-of-wst11-in-patients-with-localized-prostate-cancer-60199https://curecurrent.com/trials/dendritic-cell-vaccine-study-dc-pc3-for-prostate-cancer-60200https://curecurrent.com/trials/a-phase-2-study-to-determine-the-safety-and-efficacy-of-bind-014-docetaxel-nanoparticles-for-injectable-suspension-admin-60201https://curecurrent.com/trials/implant-and-external-radiation-for-prostate-cancer-with-or-without-hormonal-therapy-a-prospective-randomized-trial-60202https://curecurrent.com/trials/global-performance-evaluation-of-the-ams-continuum-device-60203https://curecurrent.com/trials/conservative-treatment-of-postprostatectomy-incontinence-60204https://curecurrent.com/trials/prostate-cancer-parameters-for-patients-receiving-proton-treatment-60205https://curecurrent.com/trials/in-vivo-dosimetry-during-prostate-cancer-radiotherapy-60206https://curecurrent.com/trials/semen-analysis-after-proton-therapy-for-prostate-cancer-60207https://curecurrent.com/trials/safety-and-efficacy-study-of-tak-700-in-patients-with-nonmetastatic-castration-resistant-prostate-cancer-and-a-rising-pr-60208https://curecurrent.com/trials/safety-study-of-tak-700-in-subjects-with-prostate-cancer-60209https://curecurrent.com/trials/expression-of-tumor-markers-in-circulating-tumor-cells-of-metastatic-hormone-sensitive-prostate-cancer-60210https://curecurrent.com/trials/ct-mri-co-registration-prostate-cancer-60211https://curecurrent.com/trials/rapid-hormonal-cycling-as-treatment-for-patients-with-prostate-cancer-the-men-s-cycle-60212https://curecurrent.com/trials/treatment-of-prostate-cancer-with-adjuvant-bevacizumab-plus-erlotinib-60213https://curecurrent.com/trials/an-open-trial-to-assess-the-efficacy-and-safety-of-oral-thalidomide-in-patients-with-hormone-refractory-prostate-cancer-60214https://curecurrent.com/trials/evaluation-of-truebeam-for-low-intermediate-risk-prostate-cancer-60215https://curecurrent.com/trials/chemotherapy-with-or-without-strontium-89-in-treating-patients-with-prostate-cancer-60216https://curecurrent.com/trials/testing-the-helpfulness-of-2-decision-aids-for-prostate-cancer-60217https://curecurrent.com/trials/study-of-abraxane-plus-hormonal-therapy-as-initial-treatment-of-unresectable-or-metastatic-prostate-cancer-60218https://curecurrent.com/trials/activity-of-trovax-alone-vs-trovax-plus-gm-csf-in-patients-with-prostate-cancer-60219https://curecurrent.com/trials/study-of-trovax-plus-docetaxel-versus-docetaxel-alone-in-patients-with-progressive-hormone-refractory-prostate-cancer-60220https://curecurrent.com/trials/efficacy-and-safety-study-of-xyotax-to-treat-prostate-cancer-60221https://curecurrent.com/trials/efficacy-and-safety-study-of-cetuximab-or-cetuximab-plus-docetaxel-to-treat-prostate-cancer-before-prostatectomy-60222https://curecurrent.com/trials/trial-of-gm-csf-given-in-combination-with-ketoconazole-and-mitoxantrone-in-patients-with-progressive-prostate-cancer-60223https://curecurrent.com/trials/safety-and-efficacy-study-of-gm-csf-thalidomide-plus-docetaxel-in-prostate-cancer-60224https://curecurrent.com/trials/randomized-trial-of-suicide-gene-therapy-and-prostate-cancer-60225https://curecurrent.com/trials/improving-assessment-and-ultimately-outcomes-of-permanent-prostate-implant-therapy-60226https://curecurrent.com/trials/external-beam-radiation-with-or-without-chemotherapy-to-treat-high-risk-prostate-cancer-60227https://curecurrent.com/trials/using-ultrasound-spectrum-analysis-usa-to-guide-dose-escalated-prostate-brachytherapy-60228https://curecurrent.com/trials/a-study-of-2-hydroxyflutamide-liproca-depot-injected-into-the-prostate-in-patients-with-localized-prostate-cancer-60229https://curecurrent.com/trials/interest-of-indocyanine-green-in-neoplastic-prostatic-tissue-60230https://curecurrent.com/trials/finasteride-in-treating-patients-with-stage-ii-prostate-cancer-who-are-undergoing-surgery-60231https://curecurrent.com/trials/study-of-blood-samples-from-older-patients-at-high-risk-of-developing-prostate-cancer-and-from-healthy-male-participants-60232https://curecurrent.com/trials/clinical-validation-of-a-urinary-exosome-gene-signature-in-men-presenting-for-suspicion-of-prostate-cancer-60233https://curecurrent.com/trials/safety-evaluation-of-exablate-mrgfus-for-prostate-cancer-60234https://curecurrent.com/trials/comparison-of-two-radiation-therapy-regimens-in-treating-patients-with-stage-ii-or-stage-iii-prostate-cancer-60235https://curecurrent.com/trials/micro-rna-expression-profiles-in-high-risk-prostate-cancer-60236https://curecurrent.com/trials/multi-site-decision-impact-study-for-decipher-60237https://curecurrent.com/trials/decision-impact-study-to-measure-the-influence-of-decipher-on-treatment-recommendations-for-radiation-oncologists-60238https://curecurrent.com/trials/blood-test-to-measure-dna-damage-in-blood-60239https://curecurrent.com/trials/development-of-a-therapeutic-education-program-for-patients-operated-for-prostate-cancer-60240https://curecurrent.com/trials/exploring-genomic-proteomic-and-dosimetric-determinants-of-late-toxicity-after-three-dimensional-conformal-radiotherapy-60241https://curecurrent.com/trials/clinico-pathologic-correlative-study-of-3t-magnetic-resonance-spectroscopy-in-the-localization-of-prostate-cancer-60242https://curecurrent.com/trials/study-to-determine-the-prevalence-of-osteoporosis-in-patients-with-advanced-prostate-cancer-treated-with-hormonal-manipu-60243https://curecurrent.com/trials/high-field-magnetic-resonance-spectroscopy-imaging-for-follow-up-of-prostate-cancer-post-brachytherapy-implantation-60244https://curecurrent.com/trials/a-pilot-study-of-exercise-in-patients-with-docetaxel-based-chemotherapy-for-hormone-refractory-prostate-cancer-60245https://curecurrent.com/trials/mathematical-modeling-analysis-of-serum-prostate-specific-antigen-after-radiotherapy-60246https://curecurrent.com/trials/the-herlev-hospital-post-radiation-therapy-for-localized-prostate-cancer-database-for-sexual-side-effects-60247https://curecurrent.com/trials/biomarker-11-dh-txb2-in-blood-and-urine-samples-from-patients-with-prostate-cancer-and-healthy-volunteers-60248https://curecurrent.com/trials/cabazitaxel-and-bkm120-in-patients-with-metastatic-castrate-resistant-prostate-cancer-mcrpc-previously-treated-with-doce-60249https://curecurrent.com/trials/exercise-intervention-for-pts-with-metastatic-castration-resistant-prostate-cancer-receiving-abiraterone-or-enzalutamide-60250https://curecurrent.com/trials/pazopanib-hydrochloride-after-leuprolide-acetate-or-goserelin-acetate-in-treating-patients-with-relapsed-prostate-cancer-60251https://curecurrent.com/trials/functional-magnetic-resonance-imaging-for-high-throughput-curietherapy-planning-in-prostate-cancer-60252https://curecurrent.com/trials/erectile-dysfunction-prostate-rt-androgen-60253https://curecurrent.com/trials/prostate-cancer-evaluation-of-targets-in-genito-urinary-screening-program-60254https://curecurrent.com/trials/a-phase-iii-trial-of-zd4054-zibotentan-endothelin-a-antagonist-in-hormone-resistant-prostate-cancer-with-bone-metastases-60255https://curecurrent.com/trials/evaluation-of-modern-mri-in-the-diagnosis-of-prostate-cancer-in-a-danish-setup-60256https://curecurrent.com/trials/adjuvant-radiation-therapy-vs-watchful-waiting-following-radical-prostatectomy-in-high-risk-prostate-cancer-60257https://curecurrent.com/trials/physical-activity-intervention-in-african-american-men-after-radical-prostatectomy-60258https://curecurrent.com/trials/effect-of-dexmedetomidine-on-heart-rate-corrected-qt-qtc-interval-prolongation-during-robotic-assisted-laparoscopic-radi-60259https://curecurrent.com/trials/cesar-study-in-prostate-cancer-with-temsirolimus-added-to-standard-docetaxel-therapy-ceptas-60260https://curecurrent.com/trials/robotic-athermal-nerve-sparing-radical-prostatectomy-60261https://curecurrent.com/trials/improved-prostate-cancer-diagnosis-combination-of-magnetic-resonance-imaging-and-biomarkers-60262https://curecurrent.com/trials/everolimus-and-gefitinib-in-treating-patients-with-progressive-glioblastoma-multiforme-or-progressive-metastatic-prostat-60263https://curecurrent.com/trials/study-of-irofulven-in-patients-with-hormone-refractory-prostate-cancer-60264https://curecurrent.com/trials/outpatient-radical-prostatectomy-surgical-and-anesthetic-considerations-60265https://curecurrent.com/trials/novel-pet-ct-agents-and-mrs-mri-in-prostate-ca-and-high-risk-prostate-cancer-an-inter-spore-collaboration-60266https://curecurrent.com/trials/open-label-prostate-cancer-study-60267https://curecurrent.com/trials/prostate-cancer-diagnosis-through-nmr-spectroscopy-of-semen-and-prostatic-secretions-60268https://curecurrent.com/trials/high-dose-rate-prostate-brachytherapy-as-salvage-for-locally-recurrent-prostate-cancer-previously-treated-with-external-60269https://curecurrent.com/trials/the-effects-of-pilates-in-muscle-strength-of-the-pelvic-floor-as-treatment-of-post-prostatectomy-urinary-incontinence-60270https://curecurrent.com/trials/lycopene-or-omega-3-fatty-acid-nutritional-supplements-in-treating-patients-with-stage-i-or-stage-ii-prostate-cancer-60271https://curecurrent.com/trials/hemiablative-focal-brachytherapy-pilot-study-60272https://curecurrent.com/trials/the-detection-of-circulating-tumor-cells-ctcs-in-patients-with-prostatic-cancer-undergoing-cryosurgery-combined-with-dc-60273https://curecurrent.com/trials/urology-database-to-evaluate-clinical-information-and-improve-patient-care-60274https://curecurrent.com/trials/multimodality-phase-ii-study-in-prostate-cancer-60275https://curecurrent.com/trials/radiation-therapy-with-or-without-bicalutamide-and-goserelin-in-treating-patients-with-prostate-cancer-60276https://curecurrent.com/trials/the-effect-of-radiation-on-semen-quality-and-fertility-in-men-with-prostate-cancer-60277https://curecurrent.com/trials/degarelix-neo-adjuvant-radical-prostatectomy-trial-60278https://curecurrent.com/trials/identification-of-predictive-factors-for-survival-of-patients-with-recurrent-prostate-cancer-from-clinical-features-tiss-60279https://curecurrent.com/trials/a-safety-and-feasibility-study-of-mitotane-in-prostate-cancer-60280https://curecurrent.com/trials/treatment-with-sandostatin-in-patients-with-castrate-resistance-prostate-cancer-showing-uptake-of-68ga-dotatet-60281https://curecurrent.com/trials/emd-525797-in-subjects-with-asymptomatic-or-mildly-symptomatic-metastatic-castrate-resistant-prostate-cancer-60282https://curecurrent.com/trials/pk-in-pts-with-hrpc-skeletal-metastes-60283https://curecurrent.com/trials/use-of-multiphoton-microscopy-in-the-diagnosis-of-cancer-60284https://curecurrent.com/trials/sexual-dysfunction-and-adaptation-in-couples-affected-by-prostate-cancer-surgery-60285https://curecurrent.com/trials/sipuleucel-t-manufacturing-demonstration-study-60286https://curecurrent.com/trials/body-mind-training-project-60287https://curecurrent.com/trials/atkins-diet-and-prostate-cancer-clinical-trial-60288https://curecurrent.com/trials/effect-of-darbepoetin-alfa-aranesp-on-anemia-in-patients-with-advanced-hormone-independent-prostate-cancer-60289https://curecurrent.com/trials/diindolylmethane-in-treating-patients-undergoing-surgery-for-stage-i-or-stage-ii-prostate-cancer-60290https://curecurrent.com/trials/using-walk-with-ease-walking-program-with-men-65-and-older-being-treated-for-prostate-cancer-60291https://curecurrent.com/trials/comparison-between-conventional-and-model-based-infusion-strategy-of-iv-pca-in-patients-undergoing-ralp-60292https://curecurrent.com/trials/toremifene-followed-by-radical-prostatectomy-in-treating-patients-with-stage-i-or-stage-ii-prostate-cancer-60293https://curecurrent.com/trials/post-marketing-surveillance-study-on-the-safety-and-effectiveness-of-abiraterone-acetate-among-adult-filipino-male-patie-60294https://curecurrent.com/trials/a-study-of-99mtc-mip-1404-and-99mtc-mip-1405-in-patients-with-metastatic-prostate-adenocarcinoma-and-healthy-volunteers-60295https://curecurrent.com/trials/99mtc-mip-1404-for-imaging-prostate-cancer-phase-i-clinical-study-to-assess-the-image-quality-of-a-simplified-kit-formul-60296https://curecurrent.com/trials/a-phase-1-pilot-study-of-99mtc-mip-1404-spect-ct-imaging-to-histology-in-men-with-prostate-cancer-60297https://curecurrent.com/trials/a-pilot-study-of-123i-mip-1072-spect-ct-imaging-with-optional-compact-gamma-camera-probe-imaging-in-men-with-prostate-ca-60298https://curecurrent.com/trials/pilot-study-of-99mtc-mip-1404-spect-ct-imaging-in-men-with-prostate-cancer-undergoing-prostatectomy-and-or-pelvic-lymph-60299https://curecurrent.com/trials/ridaforolimus-ap23573-mk-8669-in-participants-with-taxane-resistant-androgen-independent-prostate-cancer-aipc-mk-8669-01-60300https://curecurrent.com/trials/a-study-of-radium-223-in-combination-with-tasquinimod-in-bone-only-metastatic-castration-resistant-prostate-cancer-60301https://curecurrent.com/trials/s0000-selenium-and-vitamin-e-in-preventing-prostate-cancer-60302https://curecurrent.com/trials/efficacy-of-extracorporeal-biofeedback-device-for-post-prostatectomy-incontinence-60303https://curecurrent.com/trials/imaging-of-high-grade-prostate-cancer-60304https://curecurrent.com/trials/radiosensitizing-and-radioprotectve-effects-of-curcumin-in-prostate-cancer-60305https://curecurrent.com/trials/stereotactic-hypofractionated-radiosurgery-for-early-stage-prostate-cancer-60306https://curecurrent.com/trials/symptoms-and-quality-of-life-qol-after-palliative-pelvic-radiation-of-prostate-and-rectal-cancers-60307https://curecurrent.com/trials/sildenafil-in-treating-erectile-dysfunction-in-patients-with-prostate-cancer-60308https://curecurrent.com/trials/pd-103-dose-de-escalation-for-early-stage-prostate-cancer-a-prospective-randomized-trial-60309https://curecurrent.com/trials/changes-in-dna-after-radiation-therapy-in-patients-with-prostate-cancer-60310https://curecurrent.com/trials/low-dose-supplemental-external-radiation-with-pd-103-versus-pd-103-alone-for-prostate-cancer-60311https://curecurrent.com/trials/measurement-of-anti-androgen-response-using-fluorine-18-fluorocholine-pet-ct-in-androgen-insensitive-prostate-cancer-60312https://curecurrent.com/trials/treatment-decision-analysis-model-for-prostate-cancer-a-randomized-trial-60313https://curecurrent.com/trials/evaluation-of-hypoxia-by-pet-with-f-miso-in-radiation-therapy-of-prostate-cancer-60314https://curecurrent.com/trials/biomarkers-of-bone-resorption-in-metastatic-prostate-cancer-60315https://curecurrent.com/trials/salvage-radiotherapy-after-radical-prostatectomy-60316https://curecurrent.com/trials/a-phase-2-study-to-evaluate-safety-and-efficacy-of-abiraterone-in-participants-with-prostate-cancer-who-have-received-do-60317https://curecurrent.com/trials/a-study-looking-at-novel-scheduling-of-cabazitaxel-for-patients-with-metastatic-prostate-cancer-60318https://curecurrent.com/trials/vitamin-d-in-treating-patients-with-prostate-cancer-60319https://curecurrent.com/trials/exogenous-testosterone-plus-dutasteride-for-the-treatment-of-castrate-metastatic-prostate-cancer-60320https://curecurrent.com/trials/positron-emission-tomography-in-prostate-cancer-60321https://curecurrent.com/trials/measurements-of-zinc-concentration-on-specimens-taken-during-trans-perineal-prostate-biopsy-60322https://curecurrent.com/trials/mri-substudy-metabolic-changes-due-to-iatrogenic-hypogonadism-60323https://curecurrent.com/trials/a-phase-1b-dose-escalation-trial-of-psk-placebo-with-docetaxel-to-treat-metastatic-castration-resistant-prostate-cancer-60324https://curecurrent.com/trials/molecular-effects-of-a-multi-carotenoids-mcs-new-agent-on-prostate-cancer-chemoprevention-60325https://curecurrent.com/trials/efficacy-study-of-abr-215050-to-treat-prostate-cancer-60326https://curecurrent.com/trials/bmtp-11-in-patients-with-castrate-resistant-prostate-cancer-with-bone-mets-60327https://curecurrent.com/trials/a-study-of-tasquinimod-in-men-with-metastatic-castrate-resistant-prostate-cancer-60328https://curecurrent.com/trials/exercise-for-physical-health-in-men-with-prostate-cancer-60329https://curecurrent.com/trials/prostate-biomarker-study-60330https://curecurrent.com/trials/androgen-blockade-therapy-with-or-without-zoledronic-acid-in-treating-patients-with-prostate-cancer-and-bone-metastases-60331https://curecurrent.com/trials/cmt-07-08-the-prostate-bed-evaluation-study-60332https://curecurrent.com/trials/dissemination-of-prostate-cancer-screening-to-pcp-s-in-african-american-communities-60333https://curecurrent.com/trials/role-of-pet-ct-with-fluorine-18-tracers-of-bone-metastases-in-prostate-cancer-60334https://curecurrent.com/trials/ipilimumab-and-gmcsf-immunotherapy-for-prostate-cancer-60335https://curecurrent.com/trials/hyperpolarized-pyruvate-injection-in-subjects-with-prostate-cancer-60336https://curecurrent.com/trials/study-of-cgc-11047-in-patients-with-metastatic-hormone-refractory-prostate-cancer-60337https://curecurrent.com/trials/s0437-long-term-follow-up-of-patients-who-were-diagnosed-with-prostate-cancer-on-pcpt-60338https://curecurrent.com/trials/efficacy-and-safety-study-of-eligard-22-5mg-with-prostate-cancer-60339https://curecurrent.com/trials/clinical-study-evaluating-targeted-biopsies-and-cytological-imprints-in-prostate-cancer-60340https://curecurrent.com/trials/deporra-coprost-assessment-of-new-fluorescence-imagery-techniques-using-prostate-chips-from-transurethral-resections-60341https://curecurrent.com/trials/a-study-of-pertuzumab-in-participants-with-prostate-cancer-60342https://curecurrent.com/trials/study-on-efficacy-pharmacokinetics-and-safety-of-two-subcutaneous-injections-of-triptorelin-embonate-6-month-formulation-60343https://curecurrent.com/trials/can-tadalafil-maintain-erectile-function-in-patients-treated-with-radiotherapy-for-prostate-cancer-60344https://curecurrent.com/trials/daily-target-guided-radiation-therapy-using-the-calypso-4d-localization-system-in-patients-who-have-had-a-prostatectomy-60345https://curecurrent.com/trials/safety-and-efficacy-study-of-mix-vaccine-in-prostate-carcinoma-patient-60346https://curecurrent.com/trials/an-extension-study-administering-ym155-to-subjects-previously-enrolled-in-another-protocol-administering-ym155-60347https://curecurrent.com/trials/sta-9090-in-castration-resistant-prostate-cancer-with-assessment-of-androgen-receptor-pathway-signaling-60348https://curecurrent.com/trials/prostate-capsule-sparing-cystectomy-and-nerve-sparing-radical-cystoprostatectomy-in-men-with-bladder-cancer-60349https://curecurrent.com/trials/a-study-into-the-effectivity-and-safety-of-firmagon-prescribed-for-treatment-of-patients-with-advanced-prostate-cancer-60350https://curecurrent.com/trials/bicalutamide-and-ridaforolimus-in-men-with-prostate-cancer-mk-8669-002-60351https://curecurrent.com/trials/phase-i-ii-study-of-vaccination-with-antigen-loaded-dendritic-cells-dcs-in-hormone-refractory-prostate-cancer-60352https://curecurrent.com/trials/an-open-label-study-of-ym155-docetaxel-in-subjects-with-advanced-hormone-refractory-prostate-cancer-and-other-solid-tumo-60353https://curecurrent.com/trials/prostate-cancer-circulating-tumor-cells-based-on-epithelial-mesenchymal-transition-biology-60354https://curecurrent.com/trials/treatment-of-hot-flushes-caused-by-leuprorelin-11-25-mg-in-prostate-adenocarcinoma-60355https://curecurrent.com/trials/metformin-and-longevity-60356https://curecurrent.com/trials/leuprorelin-associated-with-radiotherapy-versus-leuprorelin-alone-in-t3-t4-or-pt3-on-biopsy-n0-m0-prostate-cancer-60357https://curecurrent.com/trials/intermittent-hormonal-therapy-with-leuprorelin-and-flutamide-in-the-treatment-of-stage-d2-or-txnxm1b-c-60358https://curecurrent.com/trials/the-effect-of-propofol-based-total-intravenous-anesthesia-on-oxidative-stress-and-nitric-oxide-60359https://curecurrent.com/trials/detection-of-micrometastases-in-lymph-nodes-of-patients-with-prostate-cancer-60360https://curecurrent.com/trials/study-of-metformin-with-simvastatin-for-men-with-prostate-carcinoma-60361https://curecurrent.com/trials/a-phase-3-comparative-study-of-tap-144-sr-6m-in-prostate-cancer-patients-previously-treated-with-hormonal-therapy-60362https://curecurrent.com/trials/phase-1-study-of-gen0101-in-patients-with-recurrence-of-crpc-60363https://curecurrent.com/trials/fluorine-f-18-sodium-fluoride-positron-emission-tomography-in-evaluating-response-to-dasatinib-in-patients-with-prostate-60364https://curecurrent.com/trials/biomarker-study-of-neoadjuvant-vitamin-e-in-patients-with-locally-treatable-prostate-cancer-60365https://curecurrent.com/trials/dose-escalation-and-safety-study-of-apc-100-for-the-treatment-of-prostate-cancer-60366https://curecurrent.com/trials/xray-volume-imaging-cone-beam-ct-prostate-cancer-60367https://curecurrent.com/trials/aqueduct-irrigation-system-clinical-protocol-medical-device-investigational-plan-60368https://curecurrent.com/trials/influence-of-selenium-on-prostate-cancer-related-biomarkers-60369https://curecurrent.com/trials/observational-program-to-assess-use-of-intermittent-adjuvant-deprivation-therapy-with-leuprorelin-lucrin-depot-in-patien-60370https://curecurrent.com/trials/intrathecal-morphine-in-robot-assisted-prostatectomy-60371https://curecurrent.com/trials/a-phase-ii-study-of-prostvac-v-vaccinia-tricom-and-prostvac-f-fowlpox-tricom-with-gm-csf-in-patients-with-psa-progressio-60372https://curecurrent.com/trials/prostate-localization-during-radiotherapy-using-a-ni-ti-stent-and-electronic-portal-imaging-protocol-ii-60373https://curecurrent.com/trials/analysis-of-the-mechanisms-of-actions-of-heat-shock-protein-hsp27-responsible-of-the-androgen-independent-evolution-in-p-60374https://curecurrent.com/trials/phase-1-2-study-of-onapristone-in-patients-with-advanced-castration-resistant-prostate-cancer-60375https://curecurrent.com/trials/one-month-degarelix-comparator-treatment-for-prostate-cancer-in-chinese-population-60376https://curecurrent.com/trials/safety-and-efficacy-study-of-pertuzumab-to-treat-castration-resistant-prostate-cancer-60377https://curecurrent.com/trials/metabolic-effects-of-treatment-in-intermediate-and-high-risk-prostate-cancer-60378https://curecurrent.com/trials/a-correlative-study-of-biomarkers-of-resistance-in-patients-with-castrate-resistant-prostate-cancer-treated-with-abirate-60379https://curecurrent.com/trials/prostate-cancer-family-care-for-patients-and-spouses-60380https://curecurrent.com/trials/study-to-assess-the-activity-of-nexrutine-in-prostate-cancer-patients-60381https://curecurrent.com/trials/active-control-of-prostatic-cancer-with-criteria-of-latence-60382https://curecurrent.com/trials/a-degarelix-trial-in-patients-with-prostate-cancer-60383https://curecurrent.com/trials/intraoperational-prostate-loge-biopsies-iprologx-after-radical-prostatovesiculectomy-60384https://curecurrent.com/trials/botox-in-men-with-prostate-cancer-with-lower-urinary-tract-symptoms-luts-benign-prostatic-hyperplasia-bph-60385https://curecurrent.com/trials/feasibility-study-of-an-intervention-therapeutic-education-for-patients-treated-with-androgen-deprivation-60386https://curecurrent.com/trials/open-registry-measuring-impact-of-genomic-testing-on-treatment-of-prostate-cancer-patients-60387https://curecurrent.com/trials/a-study-of-positron-emission-tomography-pet-with-89-zr-df-iab2m-in-patients-with-high-risk-prostate-cancer-60388https://curecurrent.com/trials/testing-decision-aids-about-early-stage-prostate-cancer-60389https://curecurrent.com/trials/calcitriol-in-preventing-prostate-cancer-in-patients-with-prostatic-intraepithelial-neoplasia-60390https://curecurrent.com/trials/a-pilot-study-of-lycopene-supplementation-in-prostatic-intraepithelial-neoplasia-60391https://curecurrent.com/trials/salvage-cryotherapy-in-recurrent-prostate-cancer-60392https://curecurrent.com/trials/a-study-of-intra-operative-autologous-retropubic-urethral-sling-on-urinary-control-after-robot-assisted-radical-prostate-60393https://curecurrent.com/trials/study-comparing-mri-ultrasound-fusion-guided-prostate-biopsy-versus-systematic-transrectal-ultrasound-guided-biopsy-60394https://curecurrent.com/trials/impact-of-preoperative-hba1c-levels-on-pathologic-features-and-oncological-outcomes-in-the-patients-with-prostate-cancer-60395https://curecurrent.com/trials/comparison-of-medical-and-surgical-treatments-of-benign-prostate-hyperplasia-in-patients-who-have-low-grade-non-muscle-i-60396https://curecurrent.com/trials/personal-patient-profile-prostate-p4-randomized-multisite-trial-60397https://curecurrent.com/trials/sipuleucel-t-as-neoadjuvant-treatment-in-prostate-cancer-60398https://curecurrent.com/trials/study-of-a-polymorphism-in-patients-with-prostate-cancer-60399https://curecurrent.com/trials/flavopiridol-in-treating-patients-with-refractory-cancer-60400https://curecurrent.com/trials/vaccine-therapy-plus-sargramostim-and-interleukin-2-compared-with-nilutamide-alone-in-treating-patients-with-prostate-ca-60401https://curecurrent.com/trials/study-using-wst11-in-patients-with-localized-prostate-cancer-60402https://curecurrent.com/trials/hormonal-ablation-imatinib-mesylate-and-docetaxel-for-patients-with-prostate-cancer-60403https://curecurrent.com/trials/an-alternative-to-a-fixed-schedule-in-management-of-prostate-cancer-60404https://curecurrent.com/trials/duration-of-suppression-of-bone-turnover-following-treatment-with-zoledronic-acid-in-men-with-metastatic-crpc-60405https://curecurrent.com/trials/mk0429-study-in-prostate-cancer-patients-with-metastatic-bone-disease-0429-011-60406https://curecurrent.com/trials/shear-wave-elastography-of-prostate-cancer-60407https://curecurrent.com/trials/ketoconazole-hydrocortisone-and-dutasteride-in-asymptomatic-hormone-refractory-prostate-cancer-60408https://curecurrent.com/trials/lymph-node-involvement-using-extended-pelvic-lymphadenectomy-in-clinically-localized-prostate-cancer-60409https://curecurrent.com/trials/a-prospective-study-of-clinical-factors-affecting-disease-progression-and-treatment-results-of-patients-with-tumors-of-t-60410https://curecurrent.com/trials/randomized-phase-ii-trial-of-doxil-with-or-without-dexamethasone-for-metastatic-hormone-refractory-prostate-cancer-60411https://curecurrent.com/trials/amg-208-tumor-microenvironment-in-metastatic-castration-resistant-prostate-cancer-mcrpc-60412https://curecurrent.com/trials/prostate-cancer-education-in-african-american-men-60413https://curecurrent.com/trials/fulvestrant-in-treating-patients-with-recurrent-prostate-cancer-60414https://curecurrent.com/trials/gene-environment-interaction-in-prostate-cancer-60415https://curecurrent.com/trials/lycopene-in-healthy-male-participants-60416https://curecurrent.com/trials/zoledronic-acid-in-the-prevention-of-skeletal-related-events-in-hormone-refractory-and-hormone-sensitive-prostate-cancer-60417https://curecurrent.com/trials/configuration-of-a-new-prostate-disease-nomogram-predicting-prostate-biopsy-outcome-60418https://curecurrent.com/trials/2013-annual-national-digital-rectal-exam-dre-day-study-60419https://curecurrent.com/trials/facilitating-shared-decisionmaking-about-prostate-cancer-screening-60420https://curecurrent.com/trials/blood-for-immune-response-to-provenge-in-hrpc-60421https://curecurrent.com/trials/treatment-decision-intervention-for-veterans-with-prostate-cancer-60422https://curecurrent.com/trials/bone-augmentation-using-particulated-biomaterial-and-autogenous-bone-stabilized-by-collagen-membrane-and-pins-pamp-60423https://curecurrent.com/trials/an-extension-study-evaluating-the-long-term-safety-and-tolerability-of-degarelix-one-month-depots-in-prostate-cancer-60424https://curecurrent.com/trials/vitamin-d-for-chemoprevention-60425https://curecurrent.com/trials/saracatinib-in-treating-patients-with-prostate-cancer-60426https://curecurrent.com/trials/calcitriol-plus-dexamethasone-in-treating-patients-with-prostate-cancer-that-has-not-responded-to-hormone-therapy-60427https://curecurrent.com/trials/vitamin-c-as-an-anti-cancer-drug-60428https://curecurrent.com/trials/study-of-oxaliplatin-and-taxotere-in-prostate-cancer-60429https://curecurrent.com/trials/randomized-study-comparing-mr-guided-in-bore-versus-mri-us-fusion-guided-prostate-biopsy-60430https://curecurrent.com/trials/linsitinib-in-treating-patients-with-asymptomatic-or-mildly-symptomatic-metastatic-prostate-cancer-60431https://curecurrent.com/trials/s0114-vaccine-therapy-in-treating-patients-with-gastric-prostate-or-ovarian-cancer-60432https://curecurrent.com/trials/clinical-trial-to-study-quality-of-life-in-prostate-cancer-patients-by-randomizing-anti-androgen-versus-total-androgen-b-60433https://curecurrent.com/trials/feasibility-and-safety-study-using-preoperative-high-dose-single-fraction-image-guided-radiotherapy-for-men-undergoing-r-60434https://curecurrent.com/trials/fenretinide-in-treating-patients-with-biochemically-recurrent-hormone-na-ve-prostate-cancer-60435https://curecurrent.com/trials/sorafenib-in-hormone-na-ve-biochemical-recurrence-of-prostate-cancer-60436https://curecurrent.com/trials/study-of-ilx651-in-patients-with-hormone-refractory-prostate-cancer-previously-treated-with-docetaxel-60437https://curecurrent.com/trials/denosumab-for-prolonging-bone-metastasis-free-survival-in-men-with-hormone-refractory-prostate-cancer-60438https://curecurrent.com/trials/dorsal-penile-block-for-post-robotic-prostatectomy-foley-discomfort-60439https://curecurrent.com/trials/study-of-geriatric-patients-aged-75-years-or-older-treated-and-cured-for-localized-prostate-cancer-case-control-study-60440https://curecurrent.com/trials/rad001-in-patients-with-metastatic-hormone-refractory-prostate-cancer-60441https://curecurrent.com/trials/developing-a-safer-and-more-accurate-device-for-biopsies-of-suspected-prostate-cancer-60442https://curecurrent.com/trials/perifosine-in-treating-patients-with-recurrent-prostate-cancer-60443https://curecurrent.com/trials/safety-and-efficacy-of-irreversible-electroporation-in-ablation-of-prostate-cancer-in-humans-60444https://curecurrent.com/trials/feasibility-study-on-a-nordic-lifestyle-intervention-trial-among-men-with-prostate-cancer-60445https://curecurrent.com/trials/sulforadex-in-healthy-human-males-mad-60446https://curecurrent.com/trials/sunitinib-malate-hormone-ablation-and-radiation-therapy-in-patients-with-prostate-cancer-60447https://curecurrent.com/trials/a-phase-ii-neoadjuvant-study-of-enzalutamide-abiraterone-acetate-dutasteride-and-degarelix-in-men-with-localized-prostat-60448https://curecurrent.com/trials/feasibility-study-of-stereotactic-body-radiotherapy-sbrt-for-localized-prostate-cancer-cyberknife-vs-vmat-60449https://curecurrent.com/trials/estramustine-docetaxel-and-zoledronate-treatment-in-hormone-refractory-adenocarcinoma-of-the-prostate-60450https://curecurrent.com/trials/oral-estramustine-and-oral-vinorelbine-in-the-treatment-of-hormone-refractory-prostate-cancer-60451https://curecurrent.com/trials/estramustine-etoposide-and-paclitaxel-treatment-for-hormonally-responsive-adenocarcinoma-of-the-prostate-60452https://curecurrent.com/trials/docetaxel-plus-capecitabine-in-newly-diagnosed-localized-or-locally-advanced-prostate-cancer-60453https://curecurrent.com/trials/tetrathiomolybdate-in-hormone-refractory-prostate-cancer-60454https://curecurrent.com/trials/early-access-to-cabazitaxel-in-patients-with-metastatic-hormone-refractory-prostate-cancer-previously-treated-with-a-doc-60455https://curecurrent.com/trials/treatment-protocol-to-monitor-the-safety-of-a-200-mg-dose-of-bicalutamide-in-patients-with-advanced-prostate-cancer-60456https://curecurrent.com/trials/a-study-of-dovitinib-with-androgen-deprivation-therapy-adt-in-patients-with-metastatic-prostate-cancer-receiving-primary-60457https://curecurrent.com/trials/study-of-ptk787-in-the-treatment-of-patients-with-non-metastatic-androgen-independent-prostate-cancer-60458https://curecurrent.com/trials/an-efficacy-and-safety-study-with-licroca-depot-a-controlled-release-product-injected-into-the-prostate-60459https://curecurrent.com/trials/single-fraction-real-time-high-dose-rate-brachytherapy-in-patients-with-low-and-intermediate-risk-prostate-cancer-60460https://curecurrent.com/trials/vesicare-for-improving-oab-symptoms-in-patients-undergoing-igrt-of-the-prostate-60461https://curecurrent.com/trials/a-multi-centre-3-arm-randomised-phase-ii-trial-of-bibf-1120-versus-bibw-2992-versus-sequential-administration-of-bibf-11-60462https://curecurrent.com/trials/comparison-of-bone-mineral-loss-in-prostate-cancer-patients-who-is-receiving-gnrh-agonist-and-plus-anti-androgen-agent-60463https://curecurrent.com/trials/evaluation-ultrasound-elasticity-tissue-strain-hardening-imaging-for-prostate-cancer-patients-undergoing-radical-prostat-60464https://curecurrent.com/trials/3t-endorectal-magnetic-resonance-spectroscopic-imaging-mrsi-of-prostate-60465https://curecurrent.com/trials/immediate-postoperative-adjuvant-hormonal-treatment-in-high-risk-localised-or-locally-advanced-prostate-cancer-patients-60466https://curecurrent.com/trials/dose-escalation-study-with-cabazitaxel-in-combination-with-daily-prednisolone-in-patients-with-hormone-refractory-prosta-60467https://curecurrent.com/trials/treatment-of-hemorrhagic-radiation-proctitis-using-the-halo-system-60468https://curecurrent.com/trials/prostate-guided-biopsy-study-evaluating-the-diagnostic-performance-of-prostate-histoscanning-60469https://curecurrent.com/trials/comparing-two-sets-of-bladder-filling-instructions-in-treating-patients-undergoing-radiation-therapy-for-prostate-cancer-60470https://curecurrent.com/trials/return-of-continence-following-robot-assisted-radical-prostatectomy-with-or-without-a-urethrovesical-sling-60471https://curecurrent.com/trials/decision-support-interventions-desi-for-prostate-cancer-screening-and-treatment-study-2-60472https://curecurrent.com/trials/r-gossypol-and-androgen-ablation-therapy-in-treating-patients-with-newly-diagnosed-metastatic-prostate-cancer-60473https://curecurrent.com/trials/degarelix-before-radical-prostatectomy-60474https://curecurrent.com/trials/early-assessment-of-treatment-response-using-functional-diffusion-mapping-60475https://curecurrent.com/trials/trial-of-prostate-cancer-patients-undergoing-active-surveillance-with-or-without-mri-guided-management-60476https://curecurrent.com/trials/se-methyl-seleno-l-cysteine-or-selenomethionine-in-preventing-prostate-cancer-in-healthy-participants-60477https://curecurrent.com/trials/cabazitaxel-plus-prednisone-with-octreotide-for-castration-resistant-prostate-cancer-crpc-previously-treated-with-doceta-60478https://curecurrent.com/trials/prostate-biomarkers-in-men-consuming-tomato-products-60479https://curecurrent.com/trials/smarttarget-therapy-60480https://curecurrent.com/trials/protection-of-rectum-from-high-radiation-doses-60481https://curecurrent.com/trials/a-phase-i-ii-study-of-odx-osteodex-in-metastatic-castration-resistant-prostate-cancer-crpc-60482https://curecurrent.com/trials/exploration-of-tumor-accumulation-of-bay94-9392-in-patients-with-cancer-60483https://curecurrent.com/trials/prothrombotic-factors-and-anaesthesia-in-prostate-cancer-60484https://curecurrent.com/trials/neoadjuvant-chemohormonal-therapy-followed-by-salvage-surgery-for-high-risk-psa-60485https://curecurrent.com/trials/single-fraction-hdr-brachytherapy-plus-hypofractionated-ebrt-for-low-risk-prostate-cancer-phase-ii-trial-60486https://curecurrent.com/trials/safety-study-of-autologous-dendritic-cells-injected-into-the-prostate-after-cryoablation-for-advanced-prostate-cancer-60487https://curecurrent.com/trials/phase-ii-study-of-asp3550-in-patients-with-prostate-cancer-60488https://curecurrent.com/trials/genomic-guided-therapy-with-dasatinib-or-nilutamide-in-metastatic-castration-resistant-prostate-cancer-60489https://curecurrent.com/trials/prevention-of-sagopilone-induced-neurotoxicity-with-acetyl-l-carnitine-alc-60490https://curecurrent.com/trials/assessment-of-hifu-induced-prostate-necrosis-with-shear-wave-ultrasound-elastography-60491https://curecurrent.com/trials/effects-of-tomato-soy-juice-on-biomarkers-in-patients-with-prostate-cancer-undergoing-prostatectomy-60492https://curecurrent.com/trials/prospective-multicentre-non-interventional-study-of-vantas-for-the-treatment-of-patients-with-advanced-prostate-cancer-60493https://curecurrent.com/trials/a-study-of-imc-a12-or-ramucirumab-plus-mitoxantrone-and-prednisone-in-prostate-cancer-60494https://curecurrent.com/trials/temsirolimus-to-reverse-androgen-insensitivity-for-castration-resistant-prostate-cancer-60495https://curecurrent.com/trials/defined-green-tea-catechins-in-treating-patients-with-prostate-cancer-undergoing-surgery-to-remove-the-prostate-60496https://curecurrent.com/trials/hdr-vs-ldr-brachytherapy-as-monotherapy-in-the-treatment-of-localized-prostate-cancer-60497https://curecurrent.com/trials/trial-comparing-intensity-modulated-radiotherapy-versus-conformal-radiotherapy-to-treat-prostate-cancer-with-hypofractio-60498https://curecurrent.com/trials/seed-movement-in-prostate-brachytherapy-implants-clinical-measurement-and-dosimetric-consequences-60499https://curecurrent.com/trials/lapatinib-ditosylate-in-treating-patients-with-a-rising-psa-indicating-recurrent-prostate-cancer-60500https://curecurrent.com/trials/effect-of-new-posterior-reconstruction-method-on-recovery-of-continence-after-robot-assisted-laparoscopic-prostatectomy-60501https://curecurrent.com/trials/study-to-assess-the-treatment-patterns-in-metastatic-castration-resistance-prostate-cancer-mcrpc-60502https://curecurrent.com/trials/safety-study-of-pelvic-and-prostatic-sib-imrt-with-long-term-androgen-deprivation-for-high-risk-localized-prostate-cance-60503https://curecurrent.com/trials/diffusion-weighted-mri-in-staging-patients-with-localized-prostate-cancer-60504https://curecurrent.com/trials/relative-bioavailability-study-of-enzalutamide-in-prostate-cancer-patients-60505https://curecurrent.com/trials/mri-ultrasound-fusion-with-contrast-enhanced-ultrasound-guidance-60506https://curecurrent.com/trials/intermittent-treatment-with-degarelix-of-patients-suffering-from-prostate-cancer-60507https://curecurrent.com/trials/prostate-cancer-antigen-3-pca-3-gene-project-60508https://curecurrent.com/trials/study-of-mdx-010-in-patients-with-metastatic-hormone-refractory-prostate-cancer-60509https://curecurrent.com/trials/urology-database-for-outcomes-research-60510https://curecurrent.com/trials/evaluating-the-effect-of-a-decision-aid-on-shared-decision-making-for-prostate-cancer-screening-60511https://curecurrent.com/trials/a-safety-and-efficacy-study-of-siltuximab-cnto-328-in-male-subjects-with-metastatic-hormone-refractory-prostate-cancer-h-60512https://curecurrent.com/trials/a-prospective-study-to-evaluate-mri-guided-biopsy-compared-with-transrectal-ultrasound-guided-biopsy-of-the-prostate-in-60513https://curecurrent.com/trials/molecular-phenotype-changes-and-personalized-treatment-for-crpc-60514https://curecurrent.com/trials/fulvestrant-in-hormone-refractory-prostate-cancer-60515https://curecurrent.com/trials/study-of-sunitinib-malate-in-patients-with-newly-diagnosed-prostate-cancer-prior-to-prostatectomy-60516https://curecurrent.com/trials/decision-making-in-unaffected-first-degree-relatives-of-prostate-cancer-patients-60517https://curecurrent.com/trials/the-use-of-rectal-balloons-in-radical-pelvic-radiotherapy-a-feasibility-study-60518https://curecurrent.com/trials/leuvectin-in-treating-patients-with-locally-recurrent-prostate-cancer-60519https://curecurrent.com/trials/leuvectin-followed-by-surgery-in-treating-patients-with-stage-ii-or-stage-iii-prostate-cancer-60520https://curecurrent.com/trials/imaging-during-surgery-in-diagnosing-patients-with-prostate-bladder-or-kidney-cancer-60521https://curecurrent.com/trials/effective-dose-of-dexmedetomidine-for-sedation-in-patients-undergoing-turp-turb-under-spinal-anesthesia-with-or-without-60522https://curecurrent.com/trials/a-study-to-determine-the-short-term-safety-of-continuous-dosing-of-abiraterone-acetate-and-prednisone-in-modified-fastin-60523https://curecurrent.com/trials/efficacy-and-safety-of-a-triptorelin-6-month-formulation-in-patients-with-advanced-prostate-cancer-60524https://curecurrent.com/trials/phase-ib-ii-study-evaluating-orteronel-without-prednisone-combined-with-itraconazole-in-men-with-castration-resistant-pr-60525https://curecurrent.com/trials/study-combining-imatinib-mesylate-gleevec-with-sorafenib-in-patients-with-androgen-independent-prostate-cancer-aipc-60526https://curecurrent.com/trials/an-observational-study-of-continuous-oral-dosing-of-abiraterone-acetate-in-castration-resistant-prostate-cancer-patients-60527https://curecurrent.com/trials/impact-of-the-geographical-factor-on-the-prostate-cancer-stage-at-hormonal-therapy-initiation-60528https://curecurrent.com/trials/bevacizumab-with-hormonal-and-radiotherapy-for-high-risk-prostate-cancer-60529https://curecurrent.com/trials/cyclooxygenase-2-cox-2-inhibitor-reduces-serum-prostatic-specific-antigen-psa-levels-60530https://curecurrent.com/trials/change-in-penile-length-following-bilateral-nerve-sparing-radical-prostatectomy-60531https://curecurrent.com/trials/evaluating-e7389-in-patients-with-hormone-refractory-prostate-cancer-with-advanced-and-or-metastatic-disease-stratified-60532https://curecurrent.com/trials/radium-223-dichloride-bay88-8223-in-castration-resistant-hormone-refractory-prostate-cancer-patients-with-bone-metastase-60533https://curecurrent.com/trials/post-operative-or-early-salvage-xrt-and-adt-for-high-risk-pca-60534https://curecurrent.com/trials/prevalence-of-neglected-side-effects-to-radical-prostatectomy-60535https://curecurrent.com/trials/whole-body-fluorine-f-18-sodium-fluoride-pet-ct-scan-and-whole-body-mri-in-finding-bone-metastases-in-patients-with-pros-60536https://curecurrent.com/trials/single-agent-temsirolimus-torisel-in-chemotherapy-na-ve-castration-resistant-prostate-cancer-patients-60537https://curecurrent.com/trials/positron-emission-tomography-computed-tomography-pet-ct-imaging-for-radiation-dosimetry-plasma-pharmacokinetics-biodistr-60538https://curecurrent.com/trials/alpharadin-radium-223-chloride-safety-and-dosimetry-with-hrpc-that-has-metastasized-to-the-skeleton-60539https://curecurrent.com/trials/gm-csf-before-surgery-in-treating-patients-with-localized-prostate-cancer-60540https://curecurrent.com/trials/a-placebo-controlled-phase-ii-study-of-bone-targeted-radium-223-in-symptomatic-hormone-refractory-prostate-cancer-60541https://curecurrent.com/trials/eribulin-mesylate-in-treating-patients-with-metastatic-prostate-cancer-that-did-not-respond-to-hormone-therapy-60542https://curecurrent.com/trials/investigating-safety-tolerability-and-efficacy-of-azd5363-in-prostate-cancer-60543https://curecurrent.com/trials/focal-therapy-for-localised-prostate-cancer-using-irreversible-electroporation-60544https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-metastatic-or-unresectable-solid-tumors-60545https://curecurrent.com/trials/genetic-investigation-of-solid-tumors-cohort-60546https://curecurrent.com/trials/testosterone-replacement-in-men-with-non-metastatic-castrate-resistant-prostate-cancer-60547https://curecurrent.com/trials/impact-of-a-printed-decision-aid-on-patients-intent-to-undertake-prostate-cancer-screening-60548https://curecurrent.com/trials/a-phase-iiib-study-of-intermittent-versus-continuous-hormone-deprivation-treatment-with-eligard-60549https://curecurrent.com/trials/efficacy-study-of-methylphenidate-hydrochloride-to-reduce-fatigue-in-prostate-cancer-patients-receiving-hormone-therapy-60550https://curecurrent.com/trials/prospective-randomized-trial-comparing-robotic-versus-open-radical-prostatectomy-60551https://curecurrent.com/trials/a-trial-of-degarelix-in-patients-with-prostate-cancer-60552https://curecurrent.com/trials/tandutinib-in-treating-patients-with-progressive-prostate-cancer-and-bone-metastases-60553https://curecurrent.com/trials/pha-739358-for-treatment-of-hormone-refractory-prostate-cancer-60554https://curecurrent.com/trials/a-study-of-cnto-328-in-patients-with-metastatic-hormone-refractory-prostate-cancer-60555https://curecurrent.com/trials/vorinostat-in-treating-patients-with-progressive-metastatic-prostate-cancer-60556https://curecurrent.com/trials/the-sparc-trial-stereotactic-prostate-ablative-radiotherapy-using-cyberknife-60557https://curecurrent.com/trials/estramustine-docetaxel-and-carboplatin-for-patients-with-hormone-refractory-prostate-cancer-progressing-after-mitoxantro-60558https://curecurrent.com/trials/doxorubicin-plus-estramustine-in-treating-patients-with-metastatic-prostate-cancer-60559https://curecurrent.com/trials/phase-ii-metronomic-dosing-etoposide-cyclophosphamide-d0-prostate-cancer-60560https://curecurrent.com/trials/phase-ii-study-of-bi-2536-in-prostate-cancer-60561https://curecurrent.com/trials/comparison-of-mri-fusion-biopsy-techniques-in-men-with-elevated-psa-and-prior-negative-prostate-biopsy-60562https://curecurrent.com/trials/neo-adjuvant-abiraterone-luteinizing-hormone-releasing-hormone-lhrh-versus-lhrh-in-prostate-cancer-60563https://curecurrent.com/trials/study-assessing-the-efficacy-and-safety-of-avodart-dutasteride-at-improving-urinary-symptoms-in-men-with-prostate-cancer-60564https://curecurrent.com/trials/prospective-investigation-of-robotic-single-port-system-60565https://curecurrent.com/trials/an-safety-and-efficacy-study-of-abiraterone-acetate-in-participants-with-advanced-prostate-cancer-who-failed-androgen-de-60566https://curecurrent.com/trials/ixabepilone-in-treating-patients-with-metastatic-prostate-cancer-60567https://curecurrent.com/trials/docetaxel-and-prednisone-with-or-without-bevacizumab-in-treating-patients-with-prostate-cancer-that-did-not-respond-to-h-60568https://curecurrent.com/trials/study-of-zoledronic-acid-for-patients-with-hormone-sensitive-bone-metastases-from-prostate-cancer-60569https://curecurrent.com/trials/ags-1c4d4-in-patients-with-advanced-hormone-refractory-prostate-cancer-60570https://curecurrent.com/trials/abiraterone-acetate-in-castration-resistant-prostate-cancer-previously-treated-with-docetaxel-based-chemotherapy-60571https://curecurrent.com/trials/abiraterone-acetate-dose-escalation-study-in-hormone-refractory-prostate-cancer-60572https://curecurrent.com/trials/safety-study-of-repeated-dosing-of-a-cytotoxic-lymphocytes-ctl-based-prostate-cancer-therapy-60573https://curecurrent.com/trials/ps-341-followed-by-removal-of-prostate-for-those-with-prostate-cancer-60574https://curecurrent.com/trials/health-effects-of-soccer-training-in-men-with-prostate-cancer-receiving-androgen-deprivation-therapy-60575https://curecurrent.com/trials/safety-and-efficacy-of-kanglaite-gelcaps-in-prostate-cancer-60576https://curecurrent.com/trials/exercising-together-an-intervention-for-prostate-cancer-survivors-and-spouses-60577https://curecurrent.com/trials/mr-guided-laser-ablation-of-prostate-bed-recurrences-60578https://curecurrent.com/trials/real-time-microscopic-imaging-during-robot-assisted-prostate-cancer-surgery-60579https://curecurrent.com/trials/pharmacokinetic-and-efficacy-study-of-nordihydroguaiaretic-acid-ndga-in-non-metastatic-recurrent-prostate-cancer-60580https://curecurrent.com/trials/prospective-randomized-trial-comparing-urinary-diversion-after-robot-assisted-radical-prostatectomy-60581https://curecurrent.com/trials/a-phase-2-study-of-trabectedin-yondelis-in-adult-male-participants-with-advanced-prostate-cancer-60582https://curecurrent.com/trials/sorafenib-to-overcome-resistance-to-systemic-chemotherapy-in-androgen-independent-prostate-cancer-60583https://curecurrent.com/trials/the-effect-of-high-dose-silybin-phytosome-in-men-with-prostate-cancer-60584https://curecurrent.com/trials/prostate-mechanical-imager-pmi-clinical-bridging-study-60585https://curecurrent.com/trials/study-of-dasatinib-and-docetaxel-in-metastatic-hormone-refractory-prostate-cancer-60586https://curecurrent.com/trials/study-evaluating-toxicity-efficacy-of-lenalidomide-revlimid-in-chemotherapy-na-ve-aipc-patients-60587https://curecurrent.com/trials/the-use-of-transperineal-ultrasound-for-radiation-therapy-treatment-planning-and-image-guidance-in-the-treatment-of-pros-60588https://curecurrent.com/trials/a-safety-and-efficacy-study-of-abiraterone-acetate-in-participants-with-prostate-cancer-who-have-failed-hormone-therapy-60589https://curecurrent.com/trials/laser-based-focal-ablation-of-low-grade-prostate-cancer-60590https://curecurrent.com/trials/phase-i-ii-study-of-asp9521-in-castrate-resistant-prostate-cancer-crpc-patients-60591https://curecurrent.com/trials/the-eldorado-eligard-docetaxel-and-radiotherapy-study-60592https://curecurrent.com/trials/the-jet-study-a-phase-i-trial-of-cabazitaxel-radiotherapy-and-long-term-androgen-deprivation-60593https://curecurrent.com/trials/11c-acetate-imaging-post-prostatectomy-60594https://curecurrent.com/trials/androgen-suppression-combined-with-elective-nodal-and-dose-escalated-radiation-therapy-60595https://curecurrent.com/trials/dose-finding-study-of-a-dna-vaccine-delivered-with-intradermal-electroporation-in-patients-with-prostate-cancer-60596https://curecurrent.com/trials/long-term-outcome-of-subjects-with-elevated-psa-in-healthy-taiwanese-men-60597https://curecurrent.com/trials/the-efficacy-of-pilates-in-the-recovery-of-post-prostatectomy-urinary-incontinence-60598https://curecurrent.com/trials/study-of-pomella-extract-to-treat-prostate-cancer-60599https://curecurrent.com/trials/oxaliplatin-and-pemetrexed-disodium-in-treating-patients-with-refractory-hormone-resistant-prostate-cancer-60600https://curecurrent.com/trials/amg-102-in-combination-with-mitoxantrone-and-prednisone-in-subjects-with-previously-treated-castrate-resistant-prostate-60601https://curecurrent.com/trials/vaccine-therapy-plus-interleukin-12-in-treating-patients-with-metastatic-prostate-cancer-that-has-not-responded-to-hormo-60602https://curecurrent.com/trials/capecitabine-and-docetaxel-in-treating-patients-with-metastatic-prostate-cancer-60603https://curecurrent.com/trials/soy-isoflavones-in-treating-patients-who-are-undergoing-radical-prostatectomy-for-stage-i-or-stage-ii-adenocarcinoma-of-60604https://curecurrent.com/trials/guided-biopsy-for-mapping-prostate-cancer-60605https://curecurrent.com/trials/impact-of-temsirolimus-therapy-on-circulating-tumor-cell-biology-in-men-with-castration-resistant-metastatic-prostate-ca-60606https://curecurrent.com/trials/s9916-combination-therapy-in-treating-patients-with-advanced-prostate-cancer-that-has-not-responded-to-hormone-therapy-60607https://curecurrent.com/trials/cyberknife-stereotactic-radiosurgery-for-low-and-intermediate-risk-prostate-cancer-60608https://curecurrent.com/trials/phase-2-study-of-g-202-in-patients-with-chemotherapy-na-ve-metastatic-castrate-resistant-prostate-cancer-60609https://curecurrent.com/trials/ge-148-002-a-phase-2-open-label-single-center-study-to-assess-ge-148-18f-injection-pet-imaging-to-detect-localized-prost-60610https://curecurrent.com/trials/stereotactic-body-radiotherapy-sbrt-with-concurrent-boost-for-low-and-intermediate-risk-prostate-cancer-60611https://curecurrent.com/trials/prevention-of-osteoporosis-in-men-with-prostate-cancer-on-androgen-deprivation-therapy-pop-study-60612https://curecurrent.com/trials/proteases-in-patients-with-prostate-cancer-that-has-spread-to-the-bone-60613https://curecurrent.com/trials/acute-effects-of-exercise-on-the-cortical-silent-period-in-prostate-cancer-patients-60614https://curecurrent.com/trials/ablatherm-integrated-imaging-high-intensity-focused-ultrasound-for-the-indication-of-low-risk-localized-prostate-cancer-60615https://curecurrent.com/trials/docetaxel-followed-by-radical-prostatectomy-in-patients-with-high-risk-localized-prostate-cancer-60616https://curecurrent.com/trials/a-study-to-determine-the-maximum-tolerated-dose-of-elesclomol-sodium-given-with-a-fixed-dose-of-docetaxel-and-prednisone-60617https://curecurrent.com/trials/transrectal-ultrasound-trus-in-finding-tumors-during-robotic-assisted-laparoscopic-surgery-60618https://curecurrent.com/trials/goserelin-flutamine-and-radiation-therapy-in-treating-patients-with-locally-advanced-prostate-cancer-60619https://curecurrent.com/trials/magnetic-resonance-imaging-transrectal-ultrasound-fusion-image-guided-prostate-biopsy-following-radical-prostatectomy-in-60620https://curecurrent.com/trials/phase-i-targeting-dominant-intraprostatic-lesion-using-mr-spectroscopy-and-hdr-brachytherapy-60621https://curecurrent.com/trials/brachytherapy-in-treating-patients-with-prostate-cancer-60622https://curecurrent.com/trials/study-to-determine-effects-of-vesicare-on-return-to-continence-post-radical-prostatectomy-part-ii-60623https://curecurrent.com/trials/a-phase-ii-trial-of-tpi-287-in-patients-with-metastatic-prostate-cancer-60624https://curecurrent.com/trials/the-effect-of-different-doses-of-remifentanil-on-kidney-function-during-robot-assisted-prostatectomy-a-retrospective-stu-60625https://curecurrent.com/trials/mri-and-magnetic-resonance-spectroscopy-imaging-in-patients-receiving-dutasteride-for-benign-prostatic-hypertrophy-and-l-60626https://curecurrent.com/trials/capsaicin-trial-assessing-capsaicin-as-a-chemopreventive-agent-for-prostate-cancer-60627https://curecurrent.com/trials/diindolylmethane-in-treating-patients-with-nonmetastatic-prostate-cancer-that-has-not-responded-to-previous-hormone-ther-60628https://curecurrent.com/trials/effectiveness-of-conversion-to-sirolimus-versus-calcineurin-inhibitor-cni-reduction-in-renal-transplant-patients-with-pr-60629https://curecurrent.com/trials/observational-non-interventional-non-comparative-real-life-data-collection-of-depo-eligard-7-5-mg-22-5-mg-and-45-mg-in-m-60630https://curecurrent.com/trials/dutasteride-followed-by-ultrasound-guided-biopsy-in-finding-prostate-cancer-60631https://curecurrent.com/trials/study-of-blood-and-tissue-samples-from-patients-receiving-androgen-deprivation-for-newly-diagnosed-prostate-cancer-60632https://curecurrent.com/trials/a-safety-study-of-zd4054-in-prior-chemotherapy-treated-patients-with-metastatic-hormone-resistant-prostate-cancer-60633https://curecurrent.com/trials/facbc-positron-emission-tomography-computed-tomography-pet-ct-used-in-the-diagnosis-of-primary-prostate-cancer-60634https://curecurrent.com/trials/hormone-therapy-plus-radiation-therapy-in-treating-patients-with-prostate-cancer-60635https://curecurrent.com/trials/external-beam-radiation-therapy-target-volume-60636https://curecurrent.com/trials/docetaxel-plus-estramustine-in-treating-patients-with-metastatic-prostate-cancer-60637https://curecurrent.com/trials/high-risk-prostate-cancer-prevention-study-60638https://curecurrent.com/trials/preoperative-magnetic-resonance-mr-imaging-of-prostate-cancer-60639https://curecurrent.com/trials/biopsy-study-comparing-mri-and-ultrasound-soft-image-fusion-guided-biopsies-and-gold-standard-prostate-biopsies-60640https://curecurrent.com/trials/decision-impact-study-to-measure-the-influence-of-decipher-on-treatment-recommendations-60641https://curecurrent.com/trials/continued-treatment-with-docetaxel-versus-switch-to-cabazitaxel-after-minor-prostate-specific-antigen-response-to-doceta-60642https://curecurrent.com/trials/study-of-red-bull-sugar-free-drink-for-reduction-of-fatigue-in-prostate-cancer-patients-receiving-lhrh-agonist-therapy-60643https://curecurrent.com/trials/dietary-intervention-with-phytochemicals-and-polyunsaturated-fatty-acids-in-prostate-cancer-patients-60644https://curecurrent.com/trials/paclitaxel-plus-estramustine-in-treating-patients-with-metastatic-prostate-cancer-60645https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-advanced-prostate-cancer-60646https://curecurrent.com/trials/r-flurbiprofen-in-treating-patients-with-localized-prostate-cancer-at-risk-of-recurrence-60647https://curecurrent.com/trials/intramuscular-injections-of-degarelix-administered-in-1-month-dosing-regimens-in-patients-with-prostate-cancer-60648https://curecurrent.com/trials/sandostatin-for-patients-with-androgen-independent-prostate-cancer-60649https://curecurrent.com/trials/a-study-to-assess-the-effect-of-abiraterone-acetate-in-male-participants-with-mild-or-moderate-hepatic-impairment-compar-60650https://curecurrent.com/trials/phase-iib-clinical-trial-of-hamsa-1-in-metastatic-castration-resistant-prostate-cancer-crpc-60651https://curecurrent.com/trials/intra-operative-trans-rectal-ultrasound-guidance-for-robot-assisted-radical-prostatectomy-60652https://curecurrent.com/trials/development-of-clinical-assessment-technique-using-multi-radiotracer-pet-mr-in-prostate-cancer-60653https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-prostate-cancer-60654https://curecurrent.com/trials/mitoxantrone-and-g-csf-in-treating-patients-with-metastatic-prostate-cancer-60655https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-prostate-cancer-that-has-not-responded-to-hormone-therapy-60656https://curecurrent.com/trials/molecular-genetic-and-genomic-assessments-from-patients-treated-with-rad001-60657https://curecurrent.com/trials/trilostane-for-androgen-independent-prostate-cancer-60658https://curecurrent.com/trials/gemox-in-docetaxel-refractory-castration-resistant-prostate-cancer-60659https://curecurrent.com/trials/the-effect-of-endurance-training-in-patients-with-prostate-cancer-60660https://curecurrent.com/trials/botulinum-toxin-injection-with-prostate-brachytherapy-60661https://curecurrent.com/trials/neoadjuvant-eflornithine-and-bicalutamide-compared-with-eflornithine-alone-bicalutamide-alone-and-no-neoadjuvant-therapy-60662https://curecurrent.com/trials/pazopanib-as-second-line-therapy-in-patients-with-metastatic-prostate-cancer-refractory-to-total-androgen-blockade-60663https://curecurrent.com/trials/efficacy-and-safety-study-of-toremifene-citrate-for-the-reduction-in-the-risk-of-new-bone-fracture-occurrences-in-men-wi-60664https://curecurrent.com/trials/a-chemoprevention-study-of-an-investigational-drug-in-men-with-high-grade-prostate-intraepithelial-neoplasia-pin-60665https://curecurrent.com/trials/toremifene-citrate-for-prevention-of-bone-fractures-in-men-with-prostate-cancer-on-androgen-deprivation-therapy-60666https://curecurrent.com/trials/pilot-study-on-focal-prostate-radio-frequency-ablation-60667https://curecurrent.com/trials/extended-study-of-prostate-specific-membrane-antigen-antibody-drug-conjugate-in-subjects-with-prostate-cancer-60668https://curecurrent.com/trials/investigation-of-the-effect-of-degarelix-in-terms-of-prostate-volume-reduction-in-prostate-cancer-patients-60669https://curecurrent.com/trials/symptomatic-study-investigating-degarelix-in-patients-suffering-from-prostate-cancer-60670https://curecurrent.com/trials/observational-longitudinal-study-of-pain-in-men-with-metastatic-castrate-resistant-prostate-cancer-60671https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-stage-i-or-stage-ii-prostate-cancer-60672https://curecurrent.com/trials/bevacizumab-hormone-therapy-and-radiation-therapy-in-treating-patients-with-locally-advanced-prostate-cancer-60673https://curecurrent.com/trials/3-ap-in-treating-patients-with-advanced-prostate-cancer-60674https://curecurrent.com/trials/brachytherapy-in-treating-patients-with-recurrent-prostate-cancer-60675https://curecurrent.com/trials/ultrasound-in-treating-patients-with-recurrent-stage-i-or-stage-ii-prostate-cancer-60676https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-non-metastatic-prostate-cancer-60677https://curecurrent.com/trials/a-study-of-androgen-deprivation-with-leuprolide-docetaxel-for-clinically-asymptomatic-prostate-cancer-participants-with-60678https://curecurrent.com/trials/prostate-specific-membrane-antigen-antibody-drug-conjugate-in-subjects-with-prostate-cancer-60679https://curecurrent.com/trials/exercise-training-among-men-with-prostate-cancer-60680https://curecurrent.com/trials/erectile-dysfunction-study-60681https://curecurrent.com/trials/gene-therapy-for-prostate-cancer-that-returns-after-radiation-therapy-60682https://curecurrent.com/trials/study-on-evaluation-of-zoledronic-acid-to-prevent-bone-loss-in-men-receiving-androgen-deprivation-therapy-for-prostate-c-60683https://curecurrent.com/trials/use-of-multi-parametric-mri-with-prostate-biopsy-for-cancer-diagnosis-60684https://curecurrent.com/trials/cabazitaxel-in-men-75-years-of-age-or-older-with-castration-resistant-prostate-cancer-60685https://curecurrent.com/trials/effect-of-androgen-suppression-on-bone-loss-in-patients-with-or-without-bone-metastases-secondary-to-prostate-cancer-60686https://curecurrent.com/trials/oral-colchicine-in-men-with-castrate-resistant-prostate-cancer-60687https://curecurrent.com/trials/sulforadex-in-healthy-volunteers-sad-60688https://curecurrent.com/trials/soy-protein-in-preventing-recurrent-cancer-in-patients-who-have-undergone-surgery-for-stage-ii-prostate-cancer-60689https://curecurrent.com/trials/lycopene-in-treating-patients-with-prostate-cancer-or-benign-prostatic-hyperplasia-60690https://curecurrent.com/trials/lycopene-in-preventing-prostate-cancer-in-healthy-participants-60691https://curecurrent.com/trials/prostate-cancer-screening-and-dietary-heterocyclic-amines-in-african-american-men-60692https://curecurrent.com/trials/low-fat-high-fiber-diet-compared-to-a-standard-diet-in-treating-patients-with-prostate-cancer-60693https://curecurrent.com/trials/monoclonal-antibody-therapy-plus-chemotherapy-followed-by-peripheral-stem-cell-transplantation-in-treating-patients-with-60694https://curecurrent.com/trials/an-open-label-phase-ii-study-with-sutent-in-patients-suffering-from-hormone-refractory-prostate-cancer-60695https://curecurrent.com/trials/communication-and-intimacy-enhancing-therapy-for-men-with-early-stage-prostate-cancer-and-their-partners-60696https://curecurrent.com/trials/hydroxyethyl-starch-and-renal-function-after-radical-prostatectomy-60697https://curecurrent.com/trials/efficacy-of-diclofenac-suppository-for-pain-control-in-ultrasound-guided-biopsy-of-prostate-60698https://curecurrent.com/trials/trial-of-print-messages-to-support-the-role-of-partners-in-promoting-provider-discussions-about-prostate-cancer-screenin-60699https://curecurrent.com/trials/randomized-crossover-trial-to-assess-the-tolerability-of-gonadotropin-releasing-hormone-gnrh-analogue-administration-60700https://curecurrent.com/trials/su5416-plus-hormone-therapy-and-radiation-therapy-in-treating-patients-with-prostate-cancer-60701https://curecurrent.com/trials/su5416-compared-to-dexamethasone-in-treating-patients-with-progressive-prostate-cancer-that-has-not-responded-to-hormone-60702https://curecurrent.com/trials/cyproterone-acetate-in-treating-patients-with-newly-diagnosed-stage-iii-or-stage-iv-prostate-cancer-60703https://curecurrent.com/trials/study-of-blood-and-tumor-samples-from-men-with-an-inherited-risk-of-prostate-cancer-60704https://curecurrent.com/trials/high-intensity-focused-ultrasound-focal-ablation-in-treating-patients-with-progressive-prostate-cancer-60705https://curecurrent.com/trials/intensity-modulated-radiation-therapy-in-treating-patients-with-prostate-cancer-60706https://curecurrent.com/trials/dutasteride-in-treating-patients-with-prostate-cancer-60707https://curecurrent.com/trials/study-of-treatment-choice-in-patients-with-localized-prostate-cancer-60708https://curecurrent.com/trials/high-intensity-focused-ultrasound-ablation-in-treating-patients-with-localized-prostate-cancer-60709https://curecurrent.com/trials/care-of-cancer-patients-with-bowel-injury-caused-by-radiation-therapy-to-the-pelvis-60710https://curecurrent.com/trials/high-intensity-focused-ultrasound-therapy-in-treating-patients-with-localized-prostate-cancer-60711https://curecurrent.com/trials/docetaxel-compared-with-observation-in-treating-patients-who-have-undergone-radical-prostatectomy-for-prostate-cancer-60712https://curecurrent.com/trials/study-of-genes-and-the-environment-in-patients-with-prostate-cancer-residing-in-the-east-anglia-trent-or-west-midlands-r-60713https://curecurrent.com/trials/high-intensity-focused-ultrasound-ablation-in-treating-patients-with-progressive-prostate-cancer-60714https://curecurrent.com/trials/gm-csf-in-treating-patients-with-relapsed-prostate-cancer-60715https://curecurrent.com/trials/neoadjuvant-study-of-in-situ-reic-dkk-3-in-prostate-cancer-60716https://curecurrent.com/trials/bicalutamide-with-or-without-enzastaurin-in-treating-patients-with-prostate-cancer-60717https://curecurrent.com/trials/safety-study-of-hemospan-in-prostatectomy-patients-60718https://curecurrent.com/trials/t-cell-immunity-during-standard-radiotherapy-in-localised-prostate-cancer-60719https://curecurrent.com/trials/study-of-tissue-blood-and-urine-samples-from-patients-with-advanced-prostate-cancer-60720https://curecurrent.com/trials/androgen-ablation-with-or-without-docetaxel-in-treating-patients-with-advanced-prostate-cancer-60721https://curecurrent.com/trials/docetaxel-and-prednisolone-with-or-without-zoledronic-acid-and-or-strontium-chloride-sr-89-in-treating-patients-with-pro-60722https://curecurrent.com/trials/androgen-deprivation-therapy-in-treating-patients-with-prostate-cancer-60723https://curecurrent.com/trials/pelvic-floor-muscle-training-and-biofeedback-or-standard-therapy-in-men-who-have-undergone-radical-prostatectomy-or-tran-60724https://curecurrent.com/trials/mri-in-diagnosing-prostate-cancer-60725https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-metastatic-prostate-cancer-that-has-not-responded-to-hormone-therapy-60726https://curecurrent.com/trials/a-study-to-compare-capsule-and-tablet-forms-of-mdv3100-enzalutamide-after-administration-of-a-single-set-dose-under-fast-60727https://curecurrent.com/trials/dose-escalation-to-dominant-intraprostatic-lesions-dil-with-mri-trus-fusion-high-dose-rate-hdr-prostate-brachytherapy-60728https://curecurrent.com/trials/evaluating-symptom-management-educational-materials-for-patients-with-prostate-cancer-60729https://curecurrent.com/trials/a-study-of-mk4827-in-participants-with-advanced-solid-tumors-or-hematologic-malignancies-mk-4827-001-am8-60730https://curecurrent.com/trials/magnetic-resonance-imaging-in-detecting-cancer-progression-in-patients-with-early-stage-prostate-cancer-undergoing-activ-60731https://curecurrent.com/trials/perioperative-changes-of-cognitive-function-according-to-jugular-vein-insufficiency-in-robot-assisted-prostatectomy-60732https://curecurrent.com/trials/estramustine-docetaxel-and-carboplatin-in-treating-patients-with-prostate-cancer-that-has-not-responded-to-hormone-thera-60733https://curecurrent.com/trials/amg-479-in-treating-patients-with-advanced-solid-tumors-or-non-hodgkin-lymphoma-60734https://curecurrent.com/trials/efficacy-of-symbiotic-in-the-reduction-of-acute-radiation-proctitis-symptoms-60735https://curecurrent.com/trials/preoperative-radiation-therapy-for-high-risk-prostate-cancer-60736https://curecurrent.com/trials/s0032-combination-chemotherapy-plus-hormone-therapy-in-treating-patients-with-metastatic-prostate-cancer-60737https://curecurrent.com/trials/periperal-blood-lymphocytes-during-prostate-rt-60738https://curecurrent.com/trials/prospective-study-of-insulin-resistance-and-cardiovascular-disease-risk-during-androgen-deprivation-therapy-for-prostate-60739https://curecurrent.com/trials/r115777-in-treating-patients-with-progressive-metastatic-prostate-cancer-that-has-not-responded-to-hormone-therapy-60740https://curecurrent.com/trials/the-effect-of-combined-general-epidural-anesthesia-versus-general-anesthesia-on-diaphragmatic-function-60741https://curecurrent.com/trials/the-value-of-multispectral-3-tesla-mri-in-active-surveillance-of-prostate-cancer-60742https://curecurrent.com/trials/prospective-observation-study-of-insulin-sensitivity-during-and-after-gonadotropin-releasing-hormone-agonist-therapy-for-60743https://curecurrent.com/trials/zoledronic-acid-to-prevent-bone-loss-during-androgen-deprivation-therapy-for-prostate-cancer-60744https://curecurrent.com/trials/radiolabeled-monoclonal-antibody-in-treating-patients-with-progressive-metastatic-androgen-independent-adenocarcinoma-ca-60745https://curecurrent.com/trials/antineoplaston-therapy-in-treating-patients-with-stage-iii-or-stage-iv-prostate-cancer-60746https://curecurrent.com/trials/paclitaxel-topotecan-and-estramustine-in-treating-patients-with-metastatic-hormone-refractory-prostate-cancer-60747https://curecurrent.com/trials/high-intensity-focused-ultrasound-in-treating-patients-with-locally-recurrent-prostate-cancer-60748https://curecurrent.com/trials/ultrasound-in-treating-patients-with-prostate-cancer-confined-to-the-prostate-60749https://curecurrent.com/trials/an-open-label-prostate-cancer-study-in-japanese-patients-60750https://curecurrent.com/trials/an-efficacy-and-safety-study-of-abiraterone-acetate-and-prednisone-in-participants-with-prostate-cancer-who-failed-andro-60751https://curecurrent.com/trials/docetaxel-and-prednisone-in-treating-patients-with-hormone-refractory-metastatic-prostate-cancer-60752https://curecurrent.com/trials/dexamethasone-aspirin-and-diethylstilbestrol-in-treating-patients-with-locally-advanced-or-metastatic-prostate-cancer-60753https://curecurrent.com/trials/lycopene-in-preventing-of-prostate-cancer-60754https://curecurrent.com/trials/lycopene-in-preventing-prostate-cancer-in-healthy-participants-60755https://curecurrent.com/trials/lycopene-in-preventing-prostate-cancer-in-patients-who-are-at-high-risk-of-developing-prostate-cancer-60756https://curecurrent.com/trials/computer-planned-radiation-therapy-in-treating-patients-with-prostate-cancer-60757https://curecurrent.com/trials/diet-and-psa-levels-in-patients-with-prostate-cancer-60758https://curecurrent.com/trials/single-dose-local-radiation-therapy-compared-with-ibandronate-in-treating-patients-with-localized-metastatic-bone-pain-60759https://curecurrent.com/trials/decision-support-interventions-desi-for-prostate-cancer-screening-study-1-60760https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-prostate-cancer-60761https://curecurrent.com/trials/biological-therapy-in-treating-patients-with-prostate-cancer-60762https://curecurrent.com/trials/cci-779-in-treating-patients-with-prostate-cancer-60763https://curecurrent.com/trials/bms-247550-in-treating-patients-with-prostate-cancer-that-has-not-responded-to-hormone-therapy-60764https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-single-agent-carlumab-an-anti-chemokine-ligand-2-ccl2-in-participants-with-metasta-60765https://curecurrent.com/trials/neoadjuvant-exisulind-in-treating-patients-who-are-undergoing-radical-prostatectomy-for-stage-ii-or-stage-iii-prostate-c-60766https://curecurrent.com/trials/ixabepilone-with-or-without-estramustine-in-treating-patients-with-progressive-prostate-cancer-60767https://curecurrent.com/trials/combination-chemotherapy-in-treating-patients-with-advanced-prostate-cancer-60768https://curecurrent.com/trials/trastuzumab-in-treating-patients-with-prostate-cancer-60769https://curecurrent.com/trials/an-efficacy-and-safety-study-of-intetumumab-cnto-95-in-participants-with-metastatic-hormone-refractory-prostate-cancer-60770https://curecurrent.com/trials/vaccine-therapy-with-or-without-docetaxel-in-treating-patients-with-metastatic-prostate-cancer-60771https://curecurrent.com/trials/ultrasound-guided-navigation-in-robot-assisted-laparoscopic-radical-prostatectomy-60772https://curecurrent.com/trials/perifosine-in-treating-patients-with-metastatic-androgen-independent-prostate-cancer-60773https://curecurrent.com/trials/suberoylanilide-hydroxamic-acid-in-treating-patients-with-advanced-solid-tumors-that-have-not-responded-to-previous-ther-60774https://curecurrent.com/trials/calcitriol-and-zoledronate-in-treating-patients-with-progressive-prostate-cancer-60775https://curecurrent.com/trials/study-in-predicting-outcome-of-patients-undergoing-radiation-therapy-for-prostate-cancer-60776https://curecurrent.com/trials/monoclonal-antibody-therapy-in-treating-patients-with-prostate-cancer-60777https://curecurrent.com/trials/monoclonal-antibody-therapy-in-treating-patients-with-prostate-cancer-60778https://curecurrent.com/trials/clasic-laryngeal-mask-airway-c-lma-and-i-gel-releated-regurgitation-and-complications-60779https://curecurrent.com/trials/a-study-to-determine-the-maximum-tolerated-dose-of-asg-5me-in-subjects-with-castration-resistant-prostate-cancer-60780https://curecurrent.com/trials/obese-patient-during-rarp-the-role-of-a-preemptive-ventilator-strategy-to-contrast-pneumoperitoneum-and-trendelenburg-po-60781https://curecurrent.com/trials/zoledronate-and-bms-275291-in-treating-patients-with-prostate-cancer-60782https://curecurrent.com/trials/combination-chemotherapy-plus-bevacizumab-in-treating-patients-with-metastatic-prostate-cancer-60783https://curecurrent.com/trials/liposomal-doxorubicin-and-thermal-therapy-in-treating-patients-with-prostate-cancer-60784https://curecurrent.com/trials/an-efficacy-trial-of-electroacupuncture-at-points-of-bilateral-bl33-for-mild-and-moderate-benign-prostatic-hyperplasia-60785https://curecurrent.com/trials/single-photon-emission-computed-tomography-spect-lymph-node-mapping-60786https://curecurrent.com/trials/prostate-cancer-active-surveillance-metformin-trial-60787https://curecurrent.com/trials/mechanical-nerve-stimulation-in-the-treatment-of-post-prostatectomy-incontinence-60788https://curecurrent.com/trials/rosiglitazone-avandia-vs-placebo-for-androgen-dependent-prostate-cancer-60789https://curecurrent.com/trials/long-term-safety-and-tolerability-of-degarelix-one-month-dosing-regimen-in-korean-patients-60790https://curecurrent.com/trials/fenretinide-in-treating-patients-with-advanced-or-metastatic-hormone-refractory-prostate-cancer-60791https://curecurrent.com/trials/frequency-of-prostate-specific-antigen-screening-in-african-american-men-in-the-san-francisco-area-60792https://curecurrent.com/trials/docetaxel-and-diethylstilbestrol-in-the-treatment-of-androgen-independent-prostate-cancer-60793https://curecurrent.com/trials/lapatinib-in-treating-patients-with-recurrent-or-metastatic-prostate-cancer-60794https://curecurrent.com/trials/comparison-of-two-insertion-technique-of-i-gel-60795https://curecurrent.com/trials/study-of-a-drug-dcvax-tm-prostate-to-treat-prostate-cancer-when-hormone-therapy-is-no-longer-effective-60796https://curecurrent.com/trials/zoledronate-plus-standard-therapy-compared-with-placebo-plus-standard-therapy-to-prevent-bone-metastases-in-patients-wit-60797https://curecurrent.com/trials/dutasteride-in-treating-patients-with-recurrent-prostate-cancer-that-did-not-respond-to-androgen-deprivation-therapy-60798https://curecurrent.com/trials/phase-ii-study-of-dasatinib-bms-354825-for-androgen-deprived-progressive-prostate-cancer-60799https://curecurrent.com/trials/prostate-cancer-treatment-and-obesity-in-zoladex-astrazeneca-treated-patients-60800https://curecurrent.com/trials/testosterone-in-castration-resistant-prostate-cancer-60801https://curecurrent.com/trials/conformal-radiotherapy-crt-alone-versus-crt-combined-with-hdr-bt-or-stereotactic-body-radiotherapy-for-prostate-cancer-60802https://curecurrent.com/trials/radiation-therapy-followed-by-surgery-in-high-risk-localized-carcinoma-of-the-prostate-60803https://curecurrent.com/trials/an-expanded-access-study-of-abiraterone-acetate-in-patients-with-advanced-prostate-cancer-who-have-completed-clinical-st-60804https://curecurrent.com/trials/a-phase-2-study-to-evaluate-safety-and-efficacy-of-abiraterone-acetate-in-male-participants-with-prostate-cancer-60805https://curecurrent.com/trials/a-pharmacokinetics-study-to-assess-abiraterone-acetate-capsule-and-tablet-formulations-in-patients-with-prostate-cancer-60806https://curecurrent.com/trials/early-stage-prostate-cancer-cohort-60807https://curecurrent.com/trials/a-qt-qtc-and-multi-dose-pharmacokinetic-study-of-abiraterone-acetate-plus-prednisone-in-patients-with-metastatic-castrat-60808https://curecurrent.com/trials/a-drug-drug-interaction-study-of-abiraterone-acetate-plus-prednisone-with-dextromethorphan-and-theophylline-in-patients-60809https://curecurrent.com/trials/quinacrine-treatment-in-patients-with-androgen-independent-prostate-cancer-60810https://curecurrent.com/trials/study-of-cp-751-871-in-combination-with-docetaxel-and-prednisone-in-patients-with-hormone-insensitive-prostate-cancer-hr-60811https://curecurrent.com/trials/comparison-of-effectiveness-of-transrectal-ultrasonography-guided-saturation-biopsy-and-10-12-core-biopsy-in-repeated-pr-60812https://curecurrent.com/trials/docetaxel-with-a-phytochemical-in-treating-patients-with-hormone-independent-metastatic-prostate-cancer-60813https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-stage-i-stage-ii-or-stage-iii-prostate-cancer-60814https://curecurrent.com/trials/dolastatin-10-in-treating-patients-with-metastatic-prostate-cancer-that-has-not-responded-to-previous-hormone-therapy-60815https://curecurrent.com/trials/isoflavones-and-radiation-therapy-in-treating-patients-with-localized-prostate-cancer-60816https://curecurrent.com/trials/prospective-randomized-trial-of-seminal-vesicle-sparing-prostatectomy-and-nerve-sparing-radical-prostatectomy-in-men-wit-60817https://curecurrent.com/trials/biological-therapy-in-treating-patients-with-prostate-cancer-60818https://curecurrent.com/trials/docetaxel-estramustine-and-thalidomide-in-treating-patients-with-prostate-cancer-previously-treated-with-hormone-therapy-60819https://curecurrent.com/trials/analysis-of-a-new-biomarker-for-prostate-cancer-diagnosis-60820https://curecurrent.com/trials/early-compared-with-delayed-hormone-therapy-in-treating-patients-with-nonmetastatic-prostate-cancer-60821https://curecurrent.com/trials/cyproterone-acetate-in-treating-hot-flashes-following-surgical-or-chemical-castration-for-prostate-cancer-60822https://curecurrent.com/trials/loop-resectoscope-in-treating-patients-with-bladder-cancer-or-benign-prostatic-hyperplasia-who-are-undergoing-transureth-60823https://curecurrent.com/trials/vaccine-therapy-plus-qs21-in-treating-patients-with-prostate-cancer-60824https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-metastatic-prostate-cancer-60825https://curecurrent.com/trials/a-long-term-extension-study-evaluating-a-one-month-dosing-regimen-of-degarelix-in-prostate-cancer-requiring-androgen-abl-60826https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-metastatic-prostate-cancer-60827https://curecurrent.com/trials/study-of-pf-00562271-including-patients-with-pancreatic-head-and-neck-prostatic-neoplasms-60828https://curecurrent.com/trials/vaccine-therapy-plus-biological-therapy-in-treating-patients-with-prostate-cancer-60829https://curecurrent.com/trials/vaccine-therapy-plus-qs21-in-treating-patients-with-progressive-prostate-cancer-60830https://curecurrent.com/trials/combination-iodine-125-seed-implants-and-lhrh-agonists-for-locally-advanced-stage-t3-prostate-cancer-60831https://curecurrent.com/trials/initiation-of-androgen-deprivation-therapy-for-prostate-cancer-using-degarelix-followed-by-leuprolide-60832https://curecurrent.com/trials/phase-i-study-of-zd4054-zibotentan-and-docetaxel-in-patients-with-metastatic-hrpc-60833https://curecurrent.com/trials/fulvestrant-in-treating-patients-with-advanced-prostate-cancer-60834https://curecurrent.com/trials/sunitinib-plus-prednisone-in-patients-with-metastatic-castration-resistant-prostate-cancer-after-failure-of-docetaxel-ch-60835https://curecurrent.com/trials/stem-cells-treatment-for-the-local-urinary-incontinence-after-a-radical-prostate-cancer-surgery-hulpuro-60836https://curecurrent.com/trials/metformin-with-standard-taxotere-and-prednisone-in-the-treatment-of-castration-resistant-prostate-cancer-60837https://curecurrent.com/trials/group-therapy-compared-with-educational-materials-in-patients-with-prostate-cancer-60838https://curecurrent.com/trials/prostacox-metastatic-prostate-chemotherapy-60839https://curecurrent.com/trials/coping-in-african-american-prostate-cancer-survivors-60840https://curecurrent.com/trials/low-intermediate-or-high-dose-suramin-in-treating-patients-with-hormone-refractory-prostate-cancer-60841https://curecurrent.com/trials/cilengitide-in-treating-patients-with-metastatic-prostate-cancer-60842https://curecurrent.com/trials/mr-guided-focused-ultrasound-treatment-of-prostate-cancer-focal-therapy-for-locally-non-advanced-disease-60843https://curecurrent.com/trials/predictive-value-of-prostate-specific-antigen-isoform-p2psa-and-its-derivates-in-the-diagnosis-of-prostate-cancer-60844https://curecurrent.com/trials/helping-african-american-prostate-cancer-survivors-and-their-partners-cope-with-challenges-after-surgery-for-prostate-ca-60845https://curecurrent.com/trials/efficacy-and-safety-study-of-vandetanib-zd-6474-in-combination-with-bicalutamide-versus-bicalutamide-alone-in-patients-w-60846https://curecurrent.com/trials/cross-linked-hyaluronan-gel-reduces-rectal-toxicity-due-to-radiation-therapy-for-prostate-cancer-60847https://curecurrent.com/trials/comparison-of-between-thinseed-and-oncoseed-for-permanent-prostate-brachytherapy-60848https://curecurrent.com/trials/assessment-of-new-radiation-oncology-technologies-and-treatments-60849https://curecurrent.com/trials/ability-of-a-new-design-of-iodine-125-seed-to-maintain-intended-position-when-implanted-in-the-prostate-60850https://curecurrent.com/trials/efficacy-and-safety-of-degarelix-one-month-dosing-regimen-in-korean-patients-with-prostate-cancer-60851https://curecurrent.com/trials/flavopiridol-in-treating-patients-with-recurrent-prostate-cancer-60852https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-metastatic-prostate-cancer-60853https://curecurrent.com/trials/radiation-therapy-after-prostatectomy-in-treating-patients-with-stage-iii-prostate-cancer-60854https://curecurrent.com/trials/apc8015-and-bevacizumab-in-treating-patients-with-prostate-cancer-60855https://curecurrent.com/trials/duke-urology-database-and-specimen-bank-60856https://curecurrent.com/trials/interleukin-12-in-treating-patients-with-refractory-advanced-stage-ovarian-cancer-or-abdominal-cancer-60857https://curecurrent.com/trials/s9917-selenium-in-preventing-cancer-in-patients-with-neoplasia-of-the-prostate-60858https://curecurrent.com/trials/trial-of-iressa-in-prostate-cancer-patients-60859https://curecurrent.com/trials/s0354-anti-il-6-chimeric-monoclonal-antibody-in-patients-with-metastatic-prostate-cancer-that-did-not-respond-to-hormone-60860https://curecurrent.com/trials/ketoconazole-dexamethasone-and-hydrocortisone-in-treating-patients-with-prostate-cancer-that-did-not-respond-to-androgen-60861https://curecurrent.com/trials/bms-275291-in-treating-patients-with-prostate-cancer-that-has-not-responded-to-hormone-therapy-60862https://curecurrent.com/trials/study-of-coronary-heart-disease-chd-heart-failure-hf-risk-in-prostate-cancer-patients-taking-casodex-or-not-60863https://curecurrent.com/trials/lenalidomide-and-gm-csf-in-treating-patients-with-prostate-cancer-60864https://curecurrent.com/trials/vaccine-therapy-plus-qs21-in-treating-patients-with-prostate-cancer-60865https://curecurrent.com/trials/gemcitabine-and-docetaxel-in-treating-patients-with-metastatic-prostate-cancer-60866https://curecurrent.com/trials/vaccine-therapy-plus-qs21-in-treating-patients-with-progressive-prostate-cancer-60867https://curecurrent.com/trials/rehabilitation-after-radiotherapy-for-prostate-cancer-60868https://curecurrent.com/trials/a-phase-ii-trial-of-calcitriol-and-naproxen-in-patients-with-recurrent-prostate-cancer-60869https://curecurrent.com/trials/sb-715992-in-treating-patients-with-metastatic-prostate-cancer-that-did-not-respond-to-docetaxel-or-paclitaxel-60870https://curecurrent.com/trials/broxuridine-plus-surgery-in-treating-patients-with-stage-i-or-stage-ii-prostate-cancer-60871https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-advanced-adenocarcinoma-of-the-prostate-prostate-cancer-60872https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-recurrent-prostate-cancer-60873https://curecurrent.com/trials/protocol-for-the-specified-clinical-experience-investigation-on-the-single-use-of-casodex-tablet-80-mg-60874https://curecurrent.com/trials/pet-ct-positron-emission-tomography-computed-tomography-imaging-for-safety-and-tolerability-and-diagnostic-performance-o-60875https://curecurrent.com/trials/pet-ct-imaging-for-radiation-dosimetry-plasma-pharmacokinetics-biodistribution-safety-and-tolerability-and-diagnostic-pe-60876https://curecurrent.com/trials/testosterone-in-treating-patients-with-progressive-prostate-cancer-that-no-longer-responds-to-hormone-therapy-60877https://curecurrent.com/trials/et-743-yondelis-in-men-with-advanced-prostate-cancer-60878https://curecurrent.com/trials/degarelix-as-second-line-hormonal-treatment-after-prostate-specific-antigen-psa-failure-in-gnrh-agonist-treated-patients-60879https://curecurrent.com/trials/safety-and-effectiveness-of-a-vaccine-for-prostate-cancer-that-uses-each-patients-own-immune-cells-60880https://curecurrent.com/trials/ct-scans-in-guiding-the-treatment-of-patients-with-prostate-cancer-who-are-undergoing-radiation-therapy-60881https://curecurrent.com/trials/choline-pet-for-evaluating-the-incidence-of-nodal-metastases-among-newly-diagnosed-patients-of-prostate-cancer-60882https://curecurrent.com/trials/photodynamic-therapy-with-lutetium-texaphyrin-in-treating-patients-with-locally-recurrent-prostate-cancer-60883https://curecurrent.com/trials/combination-chemotherapy-plus-warfarin-in-treating-patients-with-prostate-cancer-60884https://curecurrent.com/trials/participation-in-procurement-of-tissue-serum-plasma-cell-bank-dna-and-rna-samples-and-urine-for-biological-studies-relat-60885https://curecurrent.com/trials/zd4054-zibotentan-in-pain-free-or-mildly-symptomatic-patients-with-prostate-cancer-and-bone-metastases-who-have-rising-s-60886https://curecurrent.com/trials/neoadjuvant-cci-779-followed-by-radical-prostatectomy-in-treating-patients-with-newly-diagnosed-prostate-cancer-who-have-60887https://curecurrent.com/trials/hormone-therapy-and-temsirolimus-in-treating-patients-with-relapsed-prostate-cancer-60888https://curecurrent.com/trials/a-long-term-safety-study-of-degarelix-in-patients-with-prostate-cancer-60889https://curecurrent.com/trials/efficacy-of-prostate-seed-implantation-for-local-control-of-early-stage-prostate-cancer-60890https://curecurrent.com/trials/the-efficacy-and-safety-of-degarelix-one-month-dosing-regimens-in-prostate-cancer-60891https://curecurrent.com/trials/trans-rectal-ultrasound-guided-trus-adverse-events-60892https://curecurrent.com/trials/a-prospective-randomized-trial-of-prostate-biopsy-protocols-comparing-the-vienna-nomogram-and-a-standard-10-core-biopsy-60893https://curecurrent.com/trials/study-of-su11248-in-men-with-advanced-prostate-cancer-60894https://curecurrent.com/trials/a-phase-1a-1b-study-to-evaluate-the-safety-of-ezn-4176-in-adult-patients-with-castration-resistant-prostate-cancer-60895https://curecurrent.com/trials/internet-based-education-for-prostate-cancer-screening-60896https://curecurrent.com/trials/a-phase-2-study-to-investigate-the-clinical-activity-of-ipi-504-in-patients-with-hormone-resistant-prostate-cancer-60897https://curecurrent.com/trials/treatment-frequency-and-satisfaction-in-patients-with-advanced-prostate-cancer-60898https://curecurrent.com/trials/acceptance-based-treatment-for-prostate-cancer-distress-60899https://curecurrent.com/trials/immune-profiles-and-circulating-tumor-cell-status-following-prostate-cryotherapy-60900https://curecurrent.com/trials/cryotherapy-with-or-without-short-term-adjuvant-androgen-deprivation-therapy-in-prostate-cancer-60901https://curecurrent.com/trials/leuprolide-bicalutamide-and-implant-radiation-therapy-in-treating-patients-with-locally-recurrent-prostate-cancer-after-60902https://curecurrent.com/trials/clinical-evaluation-of-the-progensa-registered-trademark-prostate-cancer-gene-3-pca3-assay-in-men-with-a-previous-negati-60903https://curecurrent.com/trials/estramustine-and-paclitaxel-in-treating-patients-with-prostate-cancer-that-has-not-responded-to-hormone-therapy-60904https://curecurrent.com/trials/red-yeast-rice-in-subjects-with-clinically-localized-prostate-cancer-undergoing-active-surveillance-60905https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-metastatic-progressive-prostate-cancer-60906https://curecurrent.com/trials/changes-in-brown-adipose-tissue-activity-in-men-receiving-androgen-deprivation-therapy-for-prostate-cancer-60907https://curecurrent.com/trials/androcur-non-interventional-study-among-patients-with-carcinoma-of-the-prostate-60908https://curecurrent.com/trials/phase-ii-study-of-docetaxel-for-clinically-asymptomatic-high-risk-prostate-cancer-patients-60909https://curecurrent.com/trials/a-phase-iia-open-label-multicenter-dose-escalation-study-to-assess-the-tolerability-and-pharmacokinetics-of-zd4054-zibot-60910https://curecurrent.com/trials/study-to-document-treatment-patterns-and-to-evaluate-leuprolide-and-alternative-therapeutic-approaches-to-the-treatments-60911https://curecurrent.com/trials/prostate-histoscanning-for-the-non-invasive-detection-and-staging-of-prostate-cancer-and-characterization-of-prostate-ti-60912https://curecurrent.com/trials/docetaxel-and-imatinib-mesylate-in-treating-patients-with-androgen-independent-prostate-cancer-and-bone-metastases-that-60913https://curecurrent.com/trials/radical-prostatectomy-and-perioperative-fluid-therapy-60914https://curecurrent.com/trials/radiation-therapy-compared-with-no-further-treatment-following-surgery-in-treating-patients-with-prostate-cancer-60915https://curecurrent.com/trials/the-physical-exercise-and-prostate-cancer-study-60916https://curecurrent.com/trials/docetaxel-with-or-without-imatinib-mesylate-in-treating-patients-with-androgen-independent-prostate-cancer-and-bone-meta-60917https://curecurrent.com/trials/nordihydroguaiaretic-acid-in-treating-patients-with-nonmetastatic-relapsed-prostate-cancer-60918https://curecurrent.com/trials/docetaxel-prednisone-and-vatalanib-in-treating-patients-with-advanced-prostate-cancer-60919https://curecurrent.com/trials/effect-of-androgen-blockade-therapy-on-thymus-function-in-older-patients-who-have-undergone-radical-prostatectomy-for-lo-60920https://curecurrent.com/trials/18f-fluorocholine-fch-positron-emission-tomography-pet-computed-tomography-ct-for-detection-of-prostate-cancer-lymph-nod-60921https://curecurrent.com/trials/evaluation-of-safety-and-feasibility-of-ogx-011-in-combination-with-2nd-line-chemotherapy-in-patients-with-hrpc-60922https://curecurrent.com/trials/neoadjuvant-study-investigating-degarelix-in-patients-suffering-from-prostate-cancer-60923https://curecurrent.com/trials/steps-for-prostate-cancer-health-and-survival-spartacus-pilot-study-of-a-walking-intervention-to-improve-health-and-qual-60924https://curecurrent.com/trials/phase-ii-trial-of-abraxane-in-front-line-therapy-of-hormone-refractory-metastatic-prostate-cancer-60925https://curecurrent.com/trials/a-phase-ii-trial-of-early-medical-adrenalectomy-for-d0-5-prostate-cancer-60926https://curecurrent.com/trials/reiki-energy-healing-in-prostate-cancer-60927https://curecurrent.com/trials/radical-prostatectomy-in-treating-patients-with-locally-advanced-prostate-cancer-60928https://curecurrent.com/trials/strontium-compared-with-radiation-therapy-in-treating-patients-with-hormone-refractory-prostate-cancer-with-painful-bone-60929https://curecurrent.com/trials/isoflavones-lycopene-in-localized-prostate-ca-prior-to-radical-prostatectomy-60930https://curecurrent.com/trials/docetaxel-with-or-without-oblimersen-in-treating-patients-with-hormone-refractory-adenocarcinoma-cancer-of-the-prostate-60931https://curecurrent.com/trials/the-specific-role-of-isoflavones-in-reducing-prostate-cancer-risk-60932https://curecurrent.com/trials/bicalutamide-compared-with-observation-followed-by-bicalutamide-plus-either-goserelin-or-orchiectomy-in-treating-patient-60933https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-enzalutamide-in-chemotherapy-na-ve-symptomatic-patients-with-metastatic-c-60934https://curecurrent.com/trials/nutrition-and-lifestyle-changes-in-patients-with-previously-untreated-stage-i-or-stage-ii-prostate-cancer-60935https://curecurrent.com/trials/mitoxantrone-and-prednisone-with-or-without-leflunomide-in-treating-patients-with-stage-iv-prostate-cancer-60936https://curecurrent.com/trials/a-phase-iii-trial-of-zd4054-zibotentan-endothelin-a-antagonist-and-docetaxel-in-metastatic-hormone-resistant-prostate-ca-60937https://curecurrent.com/trials/the-effect-of-endurance-training-on-body-composition-and-insulin-sensitivity-in-prostate-cancer-patients-receiving-andro-60938https://curecurrent.com/trials/a-phase-iii-trial-of-zd4054-zibotentan-endothelin-a-antagonist-in-non-metastatic-hormone-resistant-prostate-cancer-60939https://curecurrent.com/trials/comparison-of-20-core-versus-12-core-prostate-biopsy-diagnostic-performance-in-the-detection-of-prostate-cancer-60940https://curecurrent.com/trials/assessing-quality-of-life-of-patients-with-prostate-cancer-60941https://curecurrent.com/trials/study-of-cep-701-in-treatment-of-prostate-cancer-60942https://curecurrent.com/trials/expanded-access-study-of-satraplatin-plus-prednisone-in-patients-with-hormone-refractory-prostate-cancer-hrpc-60943https://curecurrent.com/trials/selenium-in-treating-patients-with-prostate-cancer-60944https://curecurrent.com/trials/selenium-in-preventing-prostate-cancer-60945https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-stage-d0-prostate-cancer-60946https://curecurrent.com/trials/green-tea-extract-and-prostate-cancer-60947https://curecurrent.com/trials/external-beam-radiation-therapy-ebrt-with-or-without-hormonal-therapy-in-prostate-cancer-60948https://curecurrent.com/trials/chemotherapy-in-treating-patients-who-have-metastatic-prostate-cancer-60949https://curecurrent.com/trials/a-validation-study-of-mr-lymphangiography-using-spio-a-new-lymphotropic-superparamagnetic-nanoparticle-contrast-60950https://curecurrent.com/trials/satraplatin-in-hormone-refractory-prostate-cancer-patients-previously-treated-with-one-cytotoxic-chemotherapy-regimen-60951https://curecurrent.com/trials/intravenous-estramustine-with-taxol-in-hormone-refractory-prostate-adenocarcinoma-60952https://curecurrent.com/trials/questionnaire-and-fall-risk-assessment-60953https://curecurrent.com/trials/clinical-study-of-su011248-in-subjects-with-high-risk-prostate-cancer-who-have-elected-to-undergo-radical-prostatectomy-60954https://curecurrent.com/trials/urodynamic-evaluation-in-post-radiation-salvage-prostatectomy-patients-60955https://curecurrent.com/trials/combination-chemotherapy-with-ketoconazole-in-treating-patients-with-prostate-cancer-60956https://curecurrent.com/trials/multicentric-study-comparing-carcinological-and-functional-results-of-surgery-60957https://curecurrent.com/trials/quality-of-life-in-men-with-high-risk-localized-prostate-cancer-60958https://curecurrent.com/trials/nerve-sparing-radical-prostatectomy-with-or-without-nerve-grafting-followed-by-standard-therapy-for-erectile-dysfunction-60959https://curecurrent.com/trials/preoperative-docetaxel-for-localized-progressive-castration-resistant-prostate-cancer-crpc-60960https://curecurrent.com/trials/tesetaxel-in-chemotherapy-naive-patients-with-progressive-castration-resistant-prostate-cancer-60961https://curecurrent.com/trials/men-10755-in-treating-patients-with-progressive-prostate-cancer-that-has-not-responded-to-hormone-therapy-60962https://curecurrent.com/trials/genistein-in-treating-patients-with-localized-prostate-cancer-who-are-planning-to-undergo-radical-prostatectomy-60963https://curecurrent.com/trials/abt-751-in-treating-patients-with-metastatic-prostate-cancer-that-did-not-respond-to-hormone-therapy-60964https://curecurrent.com/trials/radiation-therapy-with-or-without-goserelin-and-cyproterone-in-treating-patients-with-prostate-cancer-60965https://curecurrent.com/trials/taxotere-prostate-cancer-new-indication-registration-trial-in-china-60966https://curecurrent.com/trials/hormone-therapy-in-treating-patients-with-advanced-prostate-cancer-60967https://curecurrent.com/trials/clinical-value-of-fec-pet-combined-with-endorectal-mri-for-pre-therapeutic-staging-of-prostate-cancer-60968https://curecurrent.com/trials/a-study-of-pre-operative-metformin-in-prostate-cancer-60969https://curecurrent.com/trials/mri-targeted-focal-laser-thermal-therapy-of-biopsy-confirmed-prostate-cancer-60970https://curecurrent.com/trials/vitamin-e-supplements-in-preventing-cancer-in-patients-at-risk-of-prostate-cancer-or-who-have-prostate-cancer-60971https://curecurrent.com/trials/ala-and-prostate-cancer-60972https://curecurrent.com/trials/adjuvant-taxotere-in-patients-with-high-risk-prostate-cancer-post-prostatectomy-and-radiation-60973https://curecurrent.com/trials/management-of-prostate-cancer-in-central-china-60974https://curecurrent.com/trials/a-study-for-the-treatment-of-hormone-refractory-prostate-cancer-hrpc-in-patients-previously-treated-with-chemotherapy-60975https://curecurrent.com/trials/ym598-in-patients-with-rising-psa-after-initial-therapy-for-localized-prostate-cancer-60976https://curecurrent.com/trials/ym598-added-to-mitoxantrone-prednisone-to-control-pain-in-metastatic-prostate-cancer-patients-no-longer-responding-to-ho-60977https://curecurrent.com/trials/bicalutamide-casodex-versus-placebo-in-patients-with-early-prostate-cancer-60978https://curecurrent.com/trials/cp-675-206-with-neoadjuvant-hormone-therapy-in-patients-with-high-risk-prostate-cancer-60979https://curecurrent.com/trials/flu-tbi-in-treating-patients-not-responding-to-previous-hormone-therapy-60980https://curecurrent.com/trials/hormone-therapy-with-or-without-squalamine-lactate-in-treating-patients-who-are-undergoing-a-radical-prostatectomy-for-l-60981https://curecurrent.com/trials/celecoxib-in-treating-patients-with-relapsed-prostate-cancer-following-radiation-therapy-or-radical-prostatectomy-60982https://curecurrent.com/trials/chemotherapy-in-treating-patients-with-prostate-cancer-60983https://curecurrent.com/trials/prostate-cancer-prevention-trial-with-quercetin-and-genistein-60984https://curecurrent.com/trials/exemestane-with-or-without-bicalutamide-in-treating-patients-with-stage-iv-prostate-cancer-60985https://curecurrent.com/trials/pii-trial-of-docetaxel-prednisone-w-sargramostim-for-hrpc-60986https://curecurrent.com/trials/a-phase-i-study-of-the-oral-platinum-agent-satraplatin-in-combination-with-weekly-docetaxel-60987https://curecurrent.com/trials/prostate-biopsy-antisepsis-60988https://curecurrent.com/trials/radiotherapy-vs-observation-for-crpc-60989https://curecurrent.com/trials/zometa-zoledronic-acid-for-prevention-of-bone-metastases-60990https://curecurrent.com/trials/the-aim-study-assessing-the-impact-of-margin-reduction-60991https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-tolerability-of-zoledronic-acid-in-patients-with-metastatic-prostate-cancer-who-can-60992https://curecurrent.com/trials/amifostine-to-protect-the-rectum-during-external-beam-radiotherapy-for-prostate-cancer-60993https://curecurrent.com/trials/safety-study-of-a-cytotoxic-lymphocytes-ctl-based-prostate-cancer-therapy-60994https://curecurrent.com/trials/sonovue-guided-prostate-biopsy-60995https://curecurrent.com/trials/genistein-in-treating-patients-with-stage-ii-stage-iii-or-stage-iv-prostate-cancer-60996https://curecurrent.com/trials/safety-and-efficacy-of-pomx-capsules-in-men-with-recurrent-prostate-cancer-an-18-month-study-60997https://curecurrent.com/trials/rnactive-derived-therapeutic-vaccine-60998https://curecurrent.com/trials/a-phase-ii-study-of-docetaxel-plus-carboplatin-in-chemonaive-hormone-refractory-prostate-cancer-hrpc-patients-60999https://curecurrent.com/trials/a-phase-i-trial-of-satraplatin-plus-radiation-therapy-for-prostate-cancer-patients-with-biochemical-recurrence-61000